Immunodiagnosis of Human Filariasis Based on Antigen Detection by Mustafa, Huma
. - * ; ? ; ' 5--'"-' • - ' . 
IMMUNODIAGNOSiS OF HUMAN FILARIASIS 
BASED ON ANTIGEN DETECTION 
Thesis Submitted iw the award of the Degree of 
Boctot of $i)tlos(opt)p 
•••-••• I ,.. ^ IN ^ X ' k A % 
BI0TECHN0L0Qy4\' 
» ^  ?m .^\ BY 
HUM A MUSTAFA,/ 
U Zc.. M Phil. (Biotech.) 4 A*' 
Dated:.... 
Approved: 
Saad Tayyab (Supervisor) 
INTERDISCIPLINARY BIOTECHNOLOGY UNIT 
ALI6ARH MUSLIM UNIVERSITY 
ALIGARH (INDIA) 
2000 
CiSECl^^ 
-2.00^ 
X . ..,•• 
r 
r 
}-f 
\ I A c e . i - J . - —••/••u;-
•^^f^j 
• : ' ^ > ' 
\^ ^'^\%^M'^^^'^f^'^^S^^^ ., 
V 5 . ^ ; - -V ' 'V^AO 
i»v' 
t»i 
V« 
IsvV; * « » • * - * 
T5543 
:b») 
.\'-,.. :,atc: 
TO 
MY DEAREST SON 
s m # r ^ , " t e ^RH Ho 173, ?ra^T^ - 226 001 {'TTOT) 
Central Drug Research Institute 
Chattar Manzil, P.O. Box 173, Lucknow-226 001 (India) 
Phone: 212411-18 (PABX) 
Fax: 091-(522J-223405/ 223938/ 229504 Gram: CENDRUG 
Email: rdot@cscdri.ren.nic.in, root@gateway.cdri.res.in 
Web: http://www.cdriindia.org 
CERTIFICATE 
This is to certify fhat the work embodied in this thesis entitled 
"Immuoodiagnosis of liuman filariasis based on antigen detection^^ has been 
carried out by Ms. Huina Mjustafa, M.Sc, M.Phil. (Biotechnology) under my 
supervision. 
She has fulfilled the requirements of the Aligarh Muslim University, 
Aligarh regarding the prescribed period of investigational work for the award of 
Ph. D. degree in Biotechnology. 
The work including in this thesis is original unless stated otherwise, and 
has not been submitted for any other degree. 
(Nmh^t A. Kaushal) 
Scientist E-I 
INTERDISCIPLINARY BIOTECHNOLOGY UNIT 
ALIGARH MUSLIM UNIVERSITY. ALIGARH-202 002 (INDIA) 
Dr.SaadTayyab 
Reader and Member 
Academic Council 
CERTIFICATE 
This is to certify that the work embodied in this thesis entitled 
"IMMUNODIAGNOSIS OF HUMAN FILARIASIS BASED ON ANTIGEN 
DETECTION", is an original work carried out by Ms. Huma Mustafa, under the 
guidance of Dr.(Mrs.) Nuzhat A. Kaushal, Assitant Director, Central Drug Research 
Institute, Lucknow, for the award of the Degree of Doctor of Philosophy in 
Biotechnology. 
Ms. Huma Mustafa was registered for her Ph.D. Degree in 
Biotechnology in Interdisciplinary Biotechnology Unit, Aligarh Muslim University, 
Aligarh for the award of the Degree of Doctor of Philosophy in Biotechnology. 
SAXDTWYAB Dr. S A   
Reader 
Tel (O) 0571-401718. (R) 0571-501587, Fax : 0571-401081, E-mail: btisamu@x400.nicgw.njc in 
Acknowledgement 
Abbreviations 
Preface 
CHAPTER I : 
CHAPTER II : 
CHAPTER III: 
CHAPTER IV: 
CONTENTS 
Introduction and 
Review of Literature 
Materials and Methods 
Results and Discussions 
Page N< 
(i-ii) 
(iii-iv) 
(v-vii) 
1-43 
44-62 
63-126 
Summary and Conclusions 127-135 
Bibliography 136-174 
I express a deep sense of gratitude to my esteemed guide, Dr. (Mrs.) 
Nuzhat A. Kamhal, Assistant Director, Division of Biochemistry, Central 
Drug Research Institute (CDRI), Lucknow under whose proficient 
supervision this work has been accomplished. I also take the previledge to 
extend my thanks to Dr. Deep C. Kaushal, Assistant Director, Division of 
Microbiohgy, CDRI, Luchiow, for his aesthetic suggestions, untiring 
guidance and fruitful criticism through which this paramount task could 
acquire the present shape. 
I also take this opportunity to express my sincere thanks to my 
respected teacher. Dr. Saad Tayyab, Lecturer, Interdisciplinary Unit of 
Biotechnology, Aligarh Muslim University (AMU), Aligarh, for his kind co-
operation and helpful advice. 
My greatfulness is also to Dr. C. M. Gupta, Director, CDRI, Lucknow 
and to Dr. A.K. Rastogi, Deputy Director and Head, Division of 
Biochemistry, CDRI, Lucknow for providing necessary laboratory facilities 
during the course of the present study. 
Thanks are due to my lab colleagues. Dr. M.M. Khan, Neelu, Ranjana, 
Namita andNeetufor their friendly cooperation and help. I acknowledge the 
technical assistance of Mr. A.K. Chqata, Mr. Ravi Kumar Shukla, Mr. Rampal 
Rawat andJagdish Prasad. 
No words could express my deepest gratitute, profound regards and 
immense love to my husband, parents, in-laws and my wonderful son for their 
forebearance and affectionate blessings enabled me to accomplish this 
dessertation. 
Financial stq^portfrom Department of Biotechnology, New Delhi and 
Council of Scientific and Industrial Research, New Delhi, is greatly 
acknowledged. 
(HUMA MUSTAFA) 
ABBREVIATIONS 
BBS 
PME 
BSA 
CIE 
CIEP 
CUE 
CNBr 
DMEM 
EDTA 
ELISA 
E-S 
HCl 
HEPES 
H2O2 
H2SO4 
HRP 
hr 
lEP 
IgG 
kD 
Itr 
M 
mM 
mf 
min 
ml 
Hi 
MoAb 
N 
NBS 
ng 
NHS 
Borate buffered saline 
Beta-mercaptoethanol 
Bovine serum albumin 
Cross Immunoelectrophoresis 
Counter current Immunoelectrophoresis 
Crossed line Immunoelectrophoresis 
Cyanogen Bromide 
Dulbecco 's modified eagle medium 
Ethylene diamine tetra acetic acid 
Enzyme-linked immunosorbent assay 
Excretory-secretory 
Hydrochloric acid 
Hydroxyl ethyl piperazine-N' -2-ethane 
sulphonic acid 
Hydrogen peroxide 
Sulphuric acid 
Horse radish peroxidase 
Hour 
Immunoelectrophoresis 
Immunoglobulin G 
Kilodalton 
Litre 
Molarity 
Milli Molar 
Microfilaria 
Minute 
Millilitre 
Microlitre 
Monoclonal antibody 
Normality 
Normal buffalo serum 
Nanograms 
Normal human serum 
(ii) 
OD 
OPD 
PBS 
PBS-Tween 
PC 
rpm 
ScES 
SDS 
SDS-PAGE 
tCIE 
TEMED 
V 
Optical Density 
Orthophenylene diamine 
Phosphate buffered saline 
Phosphate buffered saline containing 
Tween-20 
Phosphorylcholine 
revolution per minute 
Setaria cervi excretory secretory antigens 
Sodium dodecyl sulphate 
SDS-polyacylamide gel electrophoresis 
Tandem crossed Immunoelectrophoresis 
NNN'N' Tetra methyl ethylene diamine 
Voltage 
(i-) 
PREFACE 
Parasitic infections of one kind or The other including 
fdariasis affect billions of people in the 'vorld mainly in the 
developing and underdeveloped countries. Although, these 
infestations do not cause morbidity, they sap the vitality of patients 
and reduce their capacity to work. Thus, these parasitic infections 
are major obstacle to economic progress and improvement of life in 
these regions. The magnitude of problem is evident from the fact 
that the World Health Organization has identified these parasitic 
infections as one of the thrust areas of research in its special 
programme of controlling tropical diseases. 
Lymphatic filariasis continues to be the scourge of the 
tropical and subtropical regions of the world inspite of extensive 
eradication efforts. The major filarial infection in India is due to 
Wuchereria bancrofti. Every third person in India faces the risk of 
exposure to fdariasis. The disease causes severe physical 
discomfort, morbidity, loss of man-hours and even social and 
psychological disturbances. Early diagnosis of the disease is still a 
(V) 
major problem and ejfective chemical or immunological remedies 
against filariasis are not available. An unequivocal diagnosis of 
filarial infection is still based on the detection of the circulating 
microfilariae in night blood smears However, this method fails to 
detect the disease when microfilariae are spares or sequestered in 
tissues. This led to the use of immunological methods for the 
diagnosis of filariasis. The immunodiagnostic methods based on 
antibody detection showed extensive cross-reactivity with other 
helminth infections and are unable to distinguish between present 
and the past infection. In the recent past, more emphasis has been 
given to the immunodiagnosis based on detection of circulating 
antigen. 
The studies reported in the present dissertation are directed 
towards the immunochemical characterization of the excretory-
secretory (E-S) products ofSetaria cervi (a bovine filarial parasite) 
which has been shown to have antigens common to the human 
filarial parasites. The study deals with the preparation, 
characterization and fractionation of 5^  cervi E-S products, 
production of polyclonal and monoclonal antibodies against the 
E-S products and evaluation of the anti-E-S antibodies (polyclonal 
and monoclonal antibodies) for the detection of circulating antigen 
in filarial patient sera. These studies provide useful information 
about the protein and antigenic make-up of S^ cervi E-S products, 
presence of antigens, equivalent to filarial circulating antigen, as 
well as the potential of anti-E-S antibodies in diagnosis of human 
filariasis. 
(vi) 
CHAPTER I 
INTRODUCTION 
AND 
REVIEW OF LITERATURE 
Lymphatic filariasis is a major public health problem in the 
tropical and subtropical countries. About 1.1 billion people are 
exposed to infection worldwide, accounting for about 20% of the total 
world population (WHO, 1997). India alone contributes about 47% of 
global prevalence of chronic patients and 39% of the population is at 
the risk of filarial infection (NFCP, 1995; WHO, 1997). The disease 
results in severe morbidity and globally is one of the most important 
cause of permanent disability (WHO, 1995). While acute episodic 
adenolymphangitis causes severe physical suffering, chronic disease 
such as lymphoedema and hydrocoele causes permanent disfigurement 
and psychosocial problems (Pani et al, 1995; Gyapong et al. ,1996; 
Ramaiah et al, 1996a), which ultimately results in loss of work, 
productivity, direct and indirect economic loss and functional 
impairment (Pani et al., 1995; Ramaiah et al., 1996b; Ramu et al, 
1996). 
The most prevalent filarial parasites that infect man and 
parasitise the lymphatics are Wuchereria bancrofti, Brugia malayi, 
and B. trimori (Sasa, 1976). In India about 90% of the infection is 
caused by W. bancrofti. Besides these, the filarial species infecting 
animals and birds are Brugia pahangi (cats), Dirofilaria immitis 
(dogs), Setaria cervi, S. digitata (catties), S. equina (horse). 
rijl. 1: Scliematic life cycle of filarial parasite 
Acanthocheilonema vitae (rodents), Litomosoides carinii (cotton rat) 
and Chandlerella hawkingii (Jungle crow). 
The mosquito vectors that transmits lymphatic filariasis are 
Culex, Aedes and Anopheles, including Mansoni. These are also 
vectors of animal filariae, which are often sympatric with filariae of 
man (Sasa, 1976; Denham and McGreevy, 1977). Filarial nematodes 
have a biphasic life cycle comprising a period of larval development in 
a blood sucking arthropod vector and the maturation and sexual 
reproduction within a vertebrate host (Fig. 1). The adult filarial 
worms are fine filiform found in the lymphatic vessels and 
glands. The females (6.5-10 cm x 0.2-2.8 mm) are longer than the 
males (4 cm x 0.1 mm). The female has a tapering anterior end with a 
slight rounded swelling. The reproductive activity of the adults leads 
to the release of microfilariae (mf) which are characteristically 
present in circulation. 
The microfilariae exhibits nocturnal periodicity, i.e. they display 
circadian rhythm with regards to the number of mf in circulation, 
which means that they are present in the peripheral blood in greater 
numbers during the night as compared to the day. The peak 
parasitemia is reached between 22.00 to 02.00 hour (hr). When the 
mosquito bites an infected individual, the salivary secretion causes 
the concentration of microfilariae near the site of bite and the 
mosquito picks up the mf during the bite (Strong et al., 1934). In the 
vector, the microfilariae undergoes metamorphosis and reaches the 
mature infective larval stage. Now again, when this infected 
mosquito bites another healthy individual, the larvae breaks free from 
the labium and penetrates through the skin thus, causing infection. The 
infective larvae passes through the peripheral blood vessels to the 
lymphatics where they undergo development process and becomes 
mature in an estimated period of three months. 
In most cases of filarial infection the parasites does not exercise 
any manifestation, therefore, a high but undefined proportion of 
infection, in endemic areas, remains undetectable until clinical 
pathology (lymphangitis and elephantiasis) develops. There are 70% 
microfilareamic cases which do not show any clinical or pathological 
sign of filarial infection. The pathological changes in W. 
bancrofti and B. malayi are related to the developmental and adult 
stages of the worms. The pathological changes in the lymphatics and 
lymph glands are the result of an immunological reaction by the host. 
The manifestations of the disease are the swelling of limbs, hydrocoele, 
elephantiasis, tropical eosinophilia, chyluria, etc or other subclinical 
abnormalities. 
The effective control of filariasis depends on early and specific 
diagnosis of filariasis. The definitive diagnosis of filarial infections in 
humans is dependent solely on microscopic confirmation of the 
presence of microfilariae in the peripheral blood in addition to the 
pafients' clinical signs and symptoms (Sasa, 1978). But the 
phenomenon of nocturnal periodicity demonstrated by many strains 
dictates that collection of samples should be carried out between 22.00 
and 02.00 hr when the peripheral microfilarial counts are at their 
highest. However, parasitological diagnosis cannot detect the 
prepatent phase of infection, obstructive lymphatic disease 
(elephantiasis) or the tropical pulmonary eosinophilia syndrome 
(Ottesen, 1980; Kagan, 1980; Piessens and Mackenzie, 1982). This 
method is also very inconvenient for both the pateint as well as the 
investigator. Furthermore, the distribution of microfilariae in the 
bloodstream may be non-random (Eberhard et al, 1988) and thus, 
making this procedure is relatively insensitive (Das et al, 1990). 
Similarly, mf are not always detectable in the blood of asymptomatic 
individuals, living in endemic areas, showing specific immunological 
reactivity to filarial antigens (Ottesen et al, 1982). 
For these reasons there has been considerable efforts focussed 
towards developing non-parasitological tests, in particular 
immunoassays for measuring antibody and circulating antigen (Kagan, 
1981). Application of immunologic methods to the diagnosis of 
lymphatic filariasis has earlier been focussed mainly on the detection 
of the host antibody response to the parasite antigens (Kagan, 1963; 
Ambroise-Thomas, 1974; Grover etal., 1977; Ottesen, 1980). Filaria 
specific antibody can be detected in the blood of individuals who have 
no apparent filarial infection as defined by clinical and parasitologic 
criteria. Furthermore, filaria-specific antibody can persist long after the 
clinically defined cure has been achieved, a fact that renders the 
measurement of antibody levels an unreliable method for 
discriminating between past and present infections. The anti-filarial 
antibodies are extensively cross-reactive (Ambroise-Thomas, 1974; 
Marcoullis and Grasbeck, 1976; Almond and Parkhouse, 1985; Cabrera 
and Parkhouse, 1987) with different filarial parasites and other 
helminths, thus the problems of specificity has always occurred with 
serologic assays employing the whole worm extracts. 
The detection of soluble circulating parasite material has been 
suggested as the most likely approach for identifying the presence of 
active infection (Frank, 1946; Harinath, 1984). Several investigations 
of individuals suffering with either onchocerciasis (Steward et al, 
1982; Des Moutis et al., 1983) or lymphatic filariasis (Au et al., 1981; 
Dissanayake et al, 1982; Kaliraj et al., 1981a) and jirds with B. 
pahangi infection (Karavodin and Ash, 1981) have demonstrated the 
presence of circulating antigen and immune complexes during the 
patent and post patent stages of infection. The development of 
immunodiagnostic tests based on the detection of circulating filarial 
antigens would be particulariy useful in epidemiological surveys of 
lymphatic filariasis as well as for monitoring the mass scale drug trails. 
Several groups of investigators have developed such assay by using 
polyclonal antibodies (Harinath, 1984; Kaliraj et al., 1979a; 1981b; 
Auetal, 1981; Oumssi et ai, 1981; Hamilton etal., 1984; Dasgupta 
et al., 1984; Weil et al., 1984a; Weil, 1990) or monoclonal antibodies 
(Des Moutis et al., 1983; Dissanayake et al., 1984; Forsyth et al., 1985; 
Weil et al., 1984b; 1985) to detect filarial antigen in the sera and urine 
of the infected individuals and animals, but the problem of sensitivity 
and specificity of these assays still remains. 
Specific antibodies against defined antigens are required for 
developing antigen detection assays. In earlier studies, the antibodies 
against the somatic antigens/extracts were employed for the detection 
of circulating antigen in filarial patient sera (Weil, 1990; Ouaissi et al., 
1981; Hamilton et al., 1984; Weil et al., 1986). The excretory-secretory 
(E-S) products, released by the living parasites in the host, are found to 
be less complex in nature and more specific in defining infection as 
compared to the somatic antigens/extracts. The fractionation and 
characterization of E-S products is of immense interest for exploration 
of their utility in immunodiagnosis and for the development of specific 
antibodies and diagnostic reagent. 
REVIEW OF LITERATURE 
The accurate diagnosis of filarial infection is a major 
requirement in the management of this disease. The identification and 
characterization of parasite-derived antigenic components appears to be 
especially important for understanding the functional immunity to the 
parasite (Thorson, 1961; Poulain et al, 1976; Ogilvie et ai, 1973) and 
for establishing specific diagnostic techniques in filarial infection. 
Various filarial antigenic preparations such as somatic extracts, surface 
antigens and excretory-secretory products, from both human as well as 
animals, have been analysed and characterized by a number of 
workers (Kwan-Lim et al, 1989; Kaushal et ai, 1982; Morgan et al, 
1986; Egwang and Kazura, 1987; Malhotra et al., 1987; Devaney, 
1988; Srivastava er a/., 1995). 
I. CHARACTERIZATION OF ANTIGENS 
The antigens of greater practical importance in filariasis are 
those related to immunodiagnosis, immunopathology and protective 
immunity. Since these are the molecules that are defined functionally 
(by eliciting an immune response), their analysis should also be 
closely integrated with functional studies. The characterization of 
parasitic-derived antigen appears to be especially important for 
identifying the antigenic molecules having protective and diagnostic 
potential (Thorson, 1951, Poulain e? a/., 1976) Filarial antigens 
such as somatic extracts, surface antigens along with the excretory-
secretory (E-S) antigens were analysed by different workers, using a 
number of biochemical, immunochemical and radiolabelling 
techniques (Forsyth et ah, 1981a; Maizels ef a/., 1982; Kaushal e/ 
a/., 1982; Malhotra ef a/., 1987). 
Several investigators have analysed the crude somatic 
extracts/antigens of the adult filarial parasites with the aim of 
identifying and characterizing these antigens (Neilson 1975; 
Dissanayake and Ismail, 1980b; 1983; Ho et al., 1986; Morgan et al., 
1986; Das et al, 1987; Kaushal et al, 1987; Maizels et al, 1987; Lai 
and Ottesen, 1988; Lammie et al., 1990; Lobos et al, 1992; Bradley 
et al., 1993a; b). In view of the non-availability of human filarial 
parasites in sufficient quantities, antigens from related animal filarial 
parasites including Setaria digitata (Dissanayake and Ismail, 
1980b), Onchocerca gibsoni (¥orsyth et al., 19%\a; Ca.tmu\\ et al., 
1994), Brugia pahangi (Maizels et al., 1982), Dirofilaria immitis 
(Weil et al, 1984; 1985; 1987) and S. cervi (Malhotra et al, 1986; 
Kaushal e? a/., 1987; Srivastava et al, 1996) have been employed 
in different studies for the characterization of somatic 
extracts/antigens. 
Several techniques were employed for the characterization of 
somatic antigens such as, gel diffusion, immunoprecipitation, SDS-
polyacrylamide gel electrophoresis (SDS-PAGE), enzyme linked 
immunosorbent assay (ELISA), western blotting/immunoblotting. The 
Immunoelectrophoresis (lEP) and crossed Immunoelectrophoresis 
(CIE) were used to analyse the antigenic pattern of somatic extracts of 
bovine filarial parasites, S. cervi (Malhotra et al., 1987; Srivastava et 
al., 1996) and Onchocerca species (Lobos and Weiss, 1986) were 
analysed by immunoelectrophoretic techniques. The 
immunoelectrophoretic analysis of the S. cervi somatic antigens 
revealed the presence of 9-10 antigenic components, whereas, 22-24 
antigens were observed on further analysis of the S. cervi somatic 
antigen by crossed Immunoelectrophoresis (CIE) showed 22-24 
antigens (Malhotra et al., 1986; Srivastava et ah, 1996). Lobos and 
Wiess (1986) have also employed the lEP technique for analysing the 
antigenic components of O. volvulus. The IE? analysis revealed 10-11 
antigenic proteins in O. volvulus. 
The SDS-polyacrylamide gel electrophoresis (SDS-PAGE), has 
been employed by a number of workers to analyse the protein pattern 
of the somatic antigens/extracts. The SDS-PAGE analysis of somatic 
extracts of the B. malayi adult worms showed 30-35 protein bands, in 
the molecular weight range of 10-200 kD (Kaushal etal, 1982). The 
same technique was used to analyse the protein pattern of adult and mf 
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stages of bovine filarial parasite, S. cervi and ( S. cervi adult somatic 
extracts showed the presence of 35-40 protein bands molecular weight 
range of 10-200 kD), while 25-29 protein bands in the micro filarial 
antigenic extracts (molecular weight range of 10-70 kD) (Malhotra et 
al, 1986; Kaushal et al, 1987; Srivastava et al, 1996). Farrar and 
others (1991) showed the presence of 42 protein bands in the 
molecular weight range of 12-160 kD by the western blot analysis of 
the B. pahangi adult somatic extracts. 
Considerable efforts have been made to analyse the surface 
antigens of filarial parasites as they appear to play a role in 
protective immunity as well as in immunodiagnosis (Maizels et al., 
1982; Sutanto et al, 1985; Selkirk et al, 1986; Philipp and Davis, 
1986; Theodore and Kaliraj, 1990; Devaney era/., 1990; Kwan-Lim 
and Maizels, 1990; Petralanda and Piessens, 1991). Analysis of the 
surface proteins by radiolabelling has suggested them to be 
antigenically simple and distinct nature of nematodes surface (Philipp 
et al, 1984; Storey and Philipp, 1990). The surface radioiodination and 
immunoprecipitation studies of O. volvulus revealed a 22 kD antigen 
which showed reactivity with sera from W. bancrofti infected 
patients (Philipp et al, 1984). Morgan and others (1986) have analysed 
the surface antigens of adult W. bancrofti using lodogen radiolabelling 
techniques and Bolton-Hunter procedures, which revealed molecules in 
the molecular weight range of 15-67 kD on the surface of W. bancrofti. 
11 
The 15, 20 and 29 kD protein bands showed resemblence with the 
pattern obtained by lodogen labelHng of both B. pahangi (Sutanto et 
al., 1985) and B. malayi (Maizels et al, 1985a). A 30 kD surface 
antigen of B. pahangi was studied by radioiodination method 
(Devaney, 1987; 1988). 
The presence of carbohydrate and glycoprotein moieties on the 
surfaces of filarial parasites was analysed by lectin binding studies. No 
appreciable carbohydrate moieties exposed on the surfaces of either 
adult or third stage larval (L3) forms of B. malayi could be detected 
(Kaushale^a/., 1984; 1989). These studies have indicated that there is 
stage specificity of the carbohydrate-containing antigens on the 
parasite surface. The dynamic change of the antigens on surface 
molecules may be either masked by host proteins or actual loss of 
surface antigens, as microfilariae matures in vivo (Kaushal et al., 1984; 
Ottesen, 1984). A major surface antigen of 35 KD was observed by 2-
dimensional gel electrophoresis on the surface of D. immitis L3 
(Philipp and Davis, 1986). 
The filarial parasites reside in lymphatics where they eat, 
excrete and procreate therefore, the parasite products are detectable in 
the blood of infected individuals. Such materials have been 
collectively termed as "excretory-secretory (E-S) products". 
Consequently, the E-S products come in close contact with the host 
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immune system, tending to provoke an immune response. The nature 
and properties of the E-S products is one of the most intriguing and 
highly speculated area of research on parasitic nematodes (Kaushal 
et al., 1984; Piessens et al., 1982; Maizels et al, 1986; 1987b; 
Sugunan and Raj, 1990). In filariasis, these materials have been 
reported to play a significant role in the survival of the parasites, 
immunopathological reactions in the host as well as in 
immunodiagnosis (Sasa, 1976; Kaushal et al, 1984; Maizels et al, 
1986; 1987a; Piessens et al, 1982; Mak et al, 1989; Parkhe et al, 
1990). 
The excretory-secretory (E-S) antigens of the filarial parasites 
were found to be less complex in nature and more specific in 
defining infection as compared to the somatic antigens (Desavigney 
and Tizard, 1977; Kaushal et al, 1982; 1984; Malhotra et al, 
1987). The importance of filarial excretory-secretory antigens to 
diagnosis and immunizationn has also been shown in onchocerciasis 
(Schiller et al, 1980) and bancroftian filariasis (Kharat et al, 1982; 
Malhotra et al, 1982; Reddy et al, 1984c; Kaushal et al, 1984; 
Harinath et al, 1984; Kaushal and Ottesen, 1987; Malhotra et al, 
1987; Dumenigo etal, 1993; Espino and Finlay, 1994). However, not 
much efforts were made to identify and characterize the excretory-
secretory products of human filarial parasites. The main reason is the 
practical difficulties in obtaining sufficient quantities of parasitic 
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materials for characterizing the antigens and their use in the available 
diagnostic procedures. First studies in this direction were done with 
that of 5. malayi E-S products (Kaushal et al., 1982). Subsequently, 
E-S products from a number of human (Maizels et al, 1986; 1987; 
Kwan-Lim et al., 1989) and animal (Parkhouse et al., 1985; Maizels 
et al., 1985a; Malhotra et al, 1987; Harnett et al., 1989; 
Thilagavathy et al., 1990; Kaneko et al., 1990) filarial parasites were 
analysed and characterized by immunochemical techniques. 
The characterization of the antigenic components of the E-S 
products of filarial parasites is essential not only to identify suitable 
antigen target but for the development of sensitive and specific 
immunodiagnostic tests (Morgan et al., 1986; Ottesen, 1984; 
Selkirk et al., 1986; Harinath, 1984; 1986). A variety of techniques 
have be?n used by several workers for the characterization of E-S 
antigens of the adult filarial parasites (Kaushal et al., 1982; Malhotra 
et al, 1987;Reddy et al., 1984c; Parkhouse etal, 1985; Maizels 
et al., 1985a; 1987b; Thilagavathy et al., 1990; Wisrewshi et al., 
1990; Mizuno et al., 1991; Zamowska and Jastrzebka, 1994). The in 
vitro released E-S products from Brugia (Kaushal et al, 1982; 
Maizels etal., 1985a; Weil, 1988b) and Wuchereria (Kaushal et al, 
1982) have been assayed for diagnostic specificities as have those for 
both adults (Daveau and Ambroise-Thomas, 1982) and 
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microfilariae (Kharat et al., 1980) and also of O. volvulus (Schiller et 
al, 1980; Ngue/^/., 1981). 
The E-S products from adult B. malayi have been identified and 
characterized by using '^ I^ radiolabelling method (Kaushal et al, 
1982; Kaushal and Ottesen, 1987). The autoradiography revealed the 
presence of 11 radioactive protein bands in the B. malayi adult E-S 
products in the molecular weight range of 10 000 to 70 000 D. Studies 
of Kaushal et al. (1982; !984) on B. malayi E-S products as well as 
studies by various workers with different filarial parasites have 
indicated that the E-S products mainly comprised of low mol.wt. 
proteins ranging between 10 to 200 kD (Kaushal et al., 1982; Maizels 
etal, 1986; Weil, 1988; Kwan-Lim et al, 1989; Parkheefa/., 1990; 
Lobos et al, 1992). Subsequent studies have also demonstrated major 
protein bands in low molecular weight regions and a few high 
molecular weight protein bands in E-S products of filarial parasites. 
Low molecular weighjt (15-82 kD) protein bands were observed in L. 
carina E-S products (Rajasekhariah et al, 1986a). Egwang and 
Kazura, (1987) have analysed the B. malayi E-S products by lodobead 
radioiodination method and have identified major protein bands of the 
mol. wt. 30, 55 and 150 kD. Mainly low mol. wt antigens of 10-22 kD 
along with few high molecular weight proteins of upto 120 kD in B. 
malayi E-S products have also been identified by the studies conducted 
by Kwan-Lim et al (1989) Kwan-Lim et al. (1989). The 29 kD 
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protein band identified as one of the major surface antigen in 
B. pahangi (Lai and Ottesen, 1988; Devaney, 1987; 1988; Maizels et 
al., 1985; Flecher and Wu, 1992). The E-S products of adult 
D. immitis male and female worms revealed the presence of 16 and 21 
protein bands respectively, while 7 and 10 protein bands were found in 
both male and female D. immitis E-S products when 
immunoblotting was employed (Kaneko et ah, 1990). 
The E-S antigens are known to be formed in the uterus during 
embryonic development (Decruize and Raj, 1988) and are released 
during moulting as secreted or excreted products (Maizels and Selkirk, 
1988a; b; Kaushal et al, 1982; Sugunan and Raj, 1986; Dhas et al, 
1993). Sugunan and Raj (1986) have also shown to have a direct 
relationship between E-S materials and the number of mf released. 
Besides, the E-S products are amongst the first parasite molecules to 
encounter the host immune system and continue to do so during the 
course of parasite's life. They may therefore, influence parasite 
survival and indeed, having a role in protective immunity against 
filariasis (Mimori et al, 1987; Ey, 1988). The E-S products may 
contribute to parasite pathology (Sisley et al, 1987), including that 
arising during drug treatment (Greene et al, 1983). 
16 
Presence of host serum proteins in the filarial E-S products 
The filarial parasites reside in the lymphatics of the host. To 
protect themselves from the immunologically hostile environment of 
the host and to evoke the immune response of the host, the filarial 
parasites are known to adsorb some of the host serum proteins on 
their surfaces. Several workers have reported the presence of 
albumin on the surface of the parasites such as the infective larvae of 
Trichenella spiralis (Parkhouse et al., 1981), O. gibsoni (Mitchell et 
al., 1982), mf of W. bancrofti (Maizels et al., 1984a; b; Kar et al., 
1993; Mania and Kar, 1994), infective larvae of W. bancrofti 
(Maizels er a/., 1986) and L. cam« (Phillip e/a/., 1984a). The 
evidence for the presence ofhost serum proteins has also been shown 
in the E-S preparation ofB. malayi (Kaushal et al., 1982), B. pahangi 
(Parkhouse et al., 1985) and a bovine filarial parasite S. cervi 
(Malhotra e/a/., 1987). 
FRACTIONATION OF THE EXCRETORY-SECRETORY 
PRODUCTS 
The fractionation of antigenic preparations may lead to the 
identification of the relevent antigen of diagnostic significance and 
thus, for developing immunodiagnostic measures for human filariasis. 
Relatively, little efforts has been made for the fractionation of E-S 
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products of the filarial parasites. The non-availability of a convenient 
and suitable animal model for W. bancrofti makes it difficult to obtain 
sufficient parasite material for immunodiagnosis of human filariasis. 
Hence, antigens shared by different filarial species have been explored 
by several workers for isolating the diagnostic important antigens 
(Hamilton et al., 1984; Ottesen et al., 1985; Weil et al., 1987; 
Cheirmaraj et al., 1990). W. bancrofti microfilaria! E-S products has 
been found to be identical to some of the active circulating filarial 
antigen fractions (CFA2-1, 9, 11 and 12) of microfilareamic cases 
(Parkhe et al, 1990). Chenthamarakshan and colleagues (1996b) 
fractionated the B. malayi microfilaria! E-S products using DEAE 
cellulose and obtained two fractions BmE DEI and BmE DE2. The 
BmE DEI was more active in binding to the immunoglobulin G 
fraction of filarial serum immunoglobulin. This fraction has a 
sensitivity and specificity of 83%. Similarly, E-S proteins of S. 
digitata was fractionated on Sephadex G150 and resolved into three 
protein components of mol. wt. 70 kD (ES FI), 16.5 kD (ES F2) and 11 
kD (ES F3) (Sugunan and Raj, 1990). The 16.5 kD (ES F2) fraction 
was found to be the major components. Later these fractions (ES F2 
and ES F3) showed 100% sensitivity in detecting human filarial 
antibodies in patients' sera. 
Homologous filarial parasite antigen isolated from blood (Reddy 
et al, 1986), hydrocoele fluids (Malhofra et al, 1985; Ramaprasad and 
Harinath, 1989) and urine (Ramaprasad and Harinath, 1987) have been 
fractionated and used as diagnostic reagent by Harinath and collegues. 
The albumin absorbed UFA-C2 fraction has shown high sensitivity in 
detecting filarial antibody (Ramaprasad and Harinath, 1987). The 
same group of workers showed positive correlation between UFA C2-
A and mfES antigen in detection of filarial antibody. Ramaprasad and 
Harinath (1995)have found that large scale isolation of UFA C2-A 
fraction from filarial urine samples or production of monoclonal 
antibodies to UFA C2-A overcomes the lack of parasite material and 
removes the difficulty in collection of mfES antigen (. 
Chenthamarakshan and others (1995) fractionated the B. malayi adult 
SDS soluble antigen and evaluated the diagnostic utility of active 
antigen fraction in bancroftian filariasis. The antigenic analysis of 
BmA SDS S Ag revealed two fi-actions BmA-6 (37-45 kD) and BmA-
9 (20-25 kD) with high antigenic activity. Antibody were produced 
against these antigen fi-actions in order to evaluate their utility in 
detection of circulating filarial antigen in bancroftian filariasis. 
III. IMMUNODIAGNOSIS 
Diagnosis of parasite infectious forms an important element is 
the identification of infected individuals and for studies on 
19 
epidemiology, protective immunity, immunopathology and control of 
disease. Highly specific tests based on detection of parasites/ parasite 
antigens and/or antibodiic requirement for specific and accurate 
diagnosis of infection. Ideally diagnostic test should be simple, 
sensitive, quantifiable and consistently reproducible. In addition, such 
test should be inexpensive and applicable for large scale field use. 
Immunodiagnosis of filariasis is one of the important area in 
filarial immunology (Kagan, 1963; 1981; Ottesen, 1984; Taylor and 
Denham, 1986). A number of immunodiagnostic tests based on 
antibody and antigen detection have been developed for human and 
animal filarial infections (Ambroise-Thomas, 1974). 
Immunodiagnostic techniques with 'low or moderate sensitivity' 
(Kagan, 1974) such as complement fixation, gel diffusion, latex 
agglutination, indirect heameagglutination and indirect 
immunoflorescence have largely been replaced by those of 'high 
sensitivity', such as radio immunoassay, immunoflouresence assays, 
enzyme linked immunosorbent assay, luminescence immunoassay, 
immunoradiometric assay etc., have been explored for the diagnosis of 
filariasis. A practical and sensitive assay would improve 
understanding of the epidemology of the disease and could be useful 
for monitoring the success of vector control efforts and drug trials 
(WHO, 1984). 
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A. Parasitological Diagnosis 
The diagnosis of filarial infections in humans still largely depends 
on an assessment of the patients' clinical signs and symptoms in 
addition to microscopic conformation for the presence of microfilariae 
(mf) circulating in peripheral blood {W. bancrofti, B. malayi) or 
dwelling in the skin {Onchocerca volvulus) (Sasa, 1978). However, 
there are technical, practical and biological factors that limit the 
usefulness of microfilaria detections as a diagnostic test for filarial 
infection. The technical limitation is that the sensitivity of such test 
depends on microfilariae counts, the volume of blood (or the number of 
skin snips in case of onchocerciasis) examined, and the skill of the 
microscopist. The microfilariae of W. bancrofti and B. malayi shows 
nocturnal periodicity and this imposes a practical limitation on the 
effective use of microfilarial detection. Moreover, this method is 
inconvenient for both the investigator as well as the patient. The 
biological limitation of microfilaria detection is that it fails to detect the 
disease when mf are sparse or sequestered inside the tissues or in 
inaccessible sites. This method is also insensitive because of 
the well recognized phenomenon of filariasis without 
microfilariae, i.e., amicrofilaremic stage (Beaver, 1970). The 
parasitological detection of microfilariae is found to be relatively 
insensitive, giving emphasis to the development of immunodiagnostic 
techniques, based on antibody and antigen detection, for filariasis. 
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B. Antibody Detection 
Application of immunological methods to the diagnosis of 
lymphatic filariasis has earlier been focussed on the detection of the 
antibody response to the parasite (Kagan, 1963; Ambroise-Thomas, 
1974; Grover et ah, 1977). Antibodies have been detected readily in 
sera of bancroftian filarial patient using hetrologous or homologous 
antigens from adults, larvae and microfilariae (mf) stages, as well as 
excretory-secretory products from filarial parasites (Ambroise-Thomas, 
1974; 1980; Chandra et al, 1974; Gonsaga dos Santos et al, 1976; 
Grover and Davies, 1978; Dissanayake and Ismail, 1981; Au et al, 
1982; Kaushal et al., 1982). A number of immunological methods 
such as gel diffusion (Petithory et a/., 1972; Khatoon e? a/., 1987), 
immunoelectrophoresis (Capron et al, 1968; 1970), counter current 
immunoelectrophoresis (Desowitz and Una, 1976; Weil et al, 1984; 
1986; Dasgupta et al., 1980), indirect haemagglutination test 
(Takahashi and Sato, 1976; Kaliraj et al, 1981a; b; Das et al, 1987), 
indirect immunoflourescent antibody test (Diesfeld et al, 1973 
Forsyth et al, 1985; Kaliraj, et al, 1981c; Das et al, 1987 
Dissanayake et al, 1984) and the skin test (Swada et al, 1969; 1975 
Swada and Sato, 1969; Gupta and Ansari, 1989) have been used for 
detecting filarial antibodies employing crude antigenic extracts from 
the homologous and heterologous filarial parasites (Ottesen et al, 
1982). 
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The skin test used previously for the diagnosis of filarial 
infection by detecting antibodies in filarial patients' sera. The test was 
carried out by subcutaneous injection of the filarial antigen in the arm 
of an individual, the response is of immediate type and can be read 
usually within 15 to 30 min, but the delayed hypersensitivity reaction 
i.e. after twenty four hour has also been noted. Wharton (1947) has 
reported that delayed reaction, due to the use of antigen in very high 
concentrations, was actually of immediate type skin reaction which 
persisted and produced exacerbation of symptoms in the infected 
individuals. The false positive results obtained with skin test may be 
attributed to cross-reaction with intestinal helminths (Bozicevich and 
Hutter, 1944; King, 1944; Hunter, 1958). The skin test showed cross-
reactivity with patients infected with hookworms and strongyloides 
(Woodruff er ai, 1958). It has also been observed that in some cases 
of elephantiasis, chyluria and hydrocoele skin test was found negative 
(Frank et al, 1947). Chandra and coworkers (1974) developed a 
filarial skin test kit using B. malayi infective larval antigen for the 
detection of antibody in filarial patient sera. This test has been 
evaluated for its sensitivity and specificity in the immunodiagnosis of 
human filariasis covering over 2500 cases from filaria endemic and 
non-endemic regions of India (Katiyar et al, 1985 and Sircar et al, 
1990). The major limitation of the kit was that the crude L3 antigen 
was used, which was prepared from the mosquito and it showed cross-
reactivity with other helminth parasites. Acton and Rao (1933) used 
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hydrocoele fluid as antigen in the skin test for the diagnosis of human 
filariasis. 
Another widely employed diagnostic test in sixties-seventies, the 
complement fixation, was found to be more sensitive than skin test 
for the diagnosis of human filariasis (Kagan, 1963). The complement 
fixation test showed fairly high sensitivity with sera of patients 
infected Loa loa whereas, fi-om W. bancrofti infected patients and 
those having other filarial infections showed comparatively less 
sensitivity (Scofield, 1957). This test also showed cross-reactivity 
against anchylostoma, schistosomiasis and stronglyoidiasis and 
infections with other intestinal parasites (Stemplen, 1944). 
The presence of filarial antibody in the serum samples of 
infected humans and animals has been reported by several 
investigators using the precipitation reaction (Biguet et al., 1962; 
Desowitz and Una, 1976; Khatoon et al., 1987). The precipitin test 
has limited use in the diagnosis of filarial infection. The antigens used 
in the test were the saline extracts of the whole worms and the results 
varied considerably. The precipitin test was found to be less sensitive 
than the skin test for the diagnosis of Mansonella ozzardi (Biagi, 
1956). Ellsworth and Johnson (1973) used diffusion capillary tubes 
for the precipitate formation using the sera of Dirqfilaria immitis. 
infected dogs. The immunodiffusion method was used by Khatoon, et 
al. (1987) for the diagnosis of Setaria cervi infection and this method 
was found to be comparatively simple and reliable. The sensitivity and 
reactivity of the precipitin test are so much lower than other 
conventional serological tests that its use for routine diagnosis can be 
hardly recommended. 
Another precipitation technique i.e. immunoelectrophoresis 
(lEP) has been used by Wheeling and Hutchinson (1971) for the 
diagnosis of human filariasis employing antigens prepared from D. 
immitis microfilariae and adults. Kaeuffer and coworkers (1974), 
however, didnot show any false positive reactions when the sera of 14 
Tahitians infected with W. bancrofti were tested in lEP using adult D. 
immitis antigen. lEP has also successfully been employed for the 
diagnosis of onchocerciasis with antigen extracted from the adult 
worms of Onchocerca (Biguet et al, 1962; 1964; Capron et al, 
1968; 1970). Using the above technique (i.e. IE?) Gentilini et al. 
(1973) have found that 8 out of 9 patients, suffering from bancroftian 
filariasis were positive for the infection, whereas, no precipitin bands 
were observed when sera of 3 patients were tested against O. volvulus 
adult antigen. The number of arcs produced have been shown to be 
related to the clinical severity of the filarial infection (D'Haussy et al., 
1972). The degree of certainty for the specificity of these precipitin 
test is not known. Wheeling and Hutchinson (1971) obtained positive 
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reaction with D. immitis antigen in case of human filariasis. On the 
other hand Kauffer and others (1974) tested a number of W. bancrofti 
microfilareamic patients with the same antigen {D. immitis aduh 
antigen) and found entirely negative results. The investigation carried 
out by Niel et al. (1972) have indicated the possibility of broad 
spectrum of antigenic specificity, and have also found that the antigens 
prepared from Setaria labiato-papillosa and Dipetalonema vitae 
produced precipitin lines in immunodiffusion and lEP against the 
sera of patients with loiasis, onchocerciasis, bancroftian filariasis and 
dracunculiasis. The above workers also reported the cross-reactivity of 
the sera of filarial patients with antigens of Ascaris suum using the 
same technique. Coimter current Immunoelectrophoresis (CIEP) was 
used by Desowitz and Una (1976) for the detection of filarial 
antibodies using D. immitis adult antigen and was found to be fairly 
sensitive. CIEP has the advantage of simplicity of performance, 
rapidity and the capability of processing relatively large numbers of 
serum samples at the same time. 
The indirect haemagglutination test (THAT) has also been 
employed for the diagnosis of human filariasis. The 
heameagglutination test was used by Jung and Harris (1960) for the 
detection of human filarial infection using somatic antigen from 
D. immitis adult worms. The IHAT employing heterologus somatic 
antigen extracts {D. immitis) showed apparent sensitivity in the 
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diagnosis of filariasis due to Achanthocheilonema perstans (Kagan et 
al., 1963) and W. bancrofti (Fujita et al, 1970) and also gave false 
positive reactions with sera from normal individuals as well as with 
patient sera harbouring other helminth infections. 
The indirect flourescent antibody test (IFAT) has been used for 
immunodiagnosis of filariasis in limited number of studies. The adult 
worm extracts of A. vitae (Ambroise-Thomas and Kein Trong, 1974), 
S. digitata (Tan et al., 1988) or sonicated W. bancrofti microfilaria! 
and larval antigens (Hedge and Ridley, 1977; Kaliraj et al, \979b; 
1981c; Das et al, 1987; 1988c) have been used in IF AT for the 
detection of filarial antibody. However, the use of 
immunoflourescence test for large scale testing of patient samples is 
tedious and requires special equipments. 
The advancement of immunological techniques led to the 
development of sensitive assays for detecting parasitic infections.The 
enzyme linked immunosorbent assay (ELISA) was found to be 
simple, sensitive and suitable for mass screening of most parasitic 
infections (Voller et al, 1974; 1975a; b; 1976a; b; Kaliraj etal, 
1981b; c). Since its development (Engvall and Pearlman, 1972) 
ELISA has been successfully used for detecting antibodies and 
antigens of a variety of organisms (Sever and Madden, 1977). In 
recent years, ELISA had been found very useful in the diagnosis of 
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many parasitic diseases including filariasis (Voller et ai, 1976a; 
Bartlett et al, 1975; Bartlett and Bidwell, 1976; Barakat e^a/., 1983; 
Gueglio et ah, 1995). Both homologous and heterologous antigens 
were used for measuring antibody response in filarial infection 
(Ruitenberg et ah, 1975; Spencer et al., 1981). A microtitre plate 
ELISA was used by Bartlett et al. (1975; 1976) for the detection of 
antibody in sera oi Onchocerca volvulus infected patients' sera but the 
use of homologous antigen was not possible as contaminants of host 
origin reacted non-specifically with the secondary antibody conjugate. 
No such problem was encountered when the same antigen was used 
after purification (Marcoullis et al, 1978). The W. bancrofti mf 
antigen and mf excretory-secretory (mf ES) antigen was used for the 
detection of filariasis by a number of workers (Kaliraj etal., 1981 b; c; 
Kharat ef a/., 1982; Malhotra er a/., 1982; Malhotra and Harinath, 
1984; Harinath et al., 1984; 1986; Dissanayake and Ismail, 1980a). In 
all these cases ELISA was found to have better sensitivity than night 
blood examination. Isolation and characterization of filarial antigens 
from urine and hydrocoele fluids have shown fair diagnostic potential 
(Ramaprasad and Harinath, 1989). The purified antigens showed high 
sensitivity and specificity when tested in sandwich ELISA (sELISA) 
(Malhotra et al, 1985a; b; Singh et al, 1993; Ramaprasad and 
Harinath, 1989; 1995) and stick enzyme immunoassay (Parkhe et al, 
1988; Ramaprasad and Harinath, 1989) for the detection of filarial 
antibodies in filarial patient sera. Besides, the use of homologous 
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antigens, heterologous antigens were also used by many workers 
for the diagnosis of human filariasis, i.e., B. malayi (Spencer e/a/., 
1981; Cheirmaraj et al, 1990; Kumar and Santhanam, 1990; 
Chanteau et al, 1991; Yuan et al, 1992; Li et al, 1993), D. immitis 
(Weil et al, 1985; 1987) and S. digitata (John et al, 1995; Dhas and 
Raj, 1995). 
The serodiagnostic tests for filariasis based on antibody 
detection were useful for testing sera from people visiting endemic 
areas, but they were not very suitable for testing sera fi^om endemic 
areas because of extensive antigenic cross-reactivity among different 
nematode antigens (Oliver-Gonzales and Morales, 1945; Kagan, 1963; 
Ambroise-Thomas, 1980). In addition, people who have been exposed 
to filarial parasites, so called 'endemic normals', often have anti-
parasite antibody titres that are at least as high as those people with 
proven infections (Ambroise-Thomas, 1980; Ottesen etal, 1982). The 
next level of refinement in antibody testing improved specificity by 
using subsets of antigens purified fi'om crude extracts (Weiss and 
Karam, 1989) or by measuring antibodies of specific isotypes (Weiss et 
al, 1982; Lai and Ottesen, 1988a; Kwan-Lim et al, 1990; Weil et al, 
1990). The IgG4 is normally a minor component of total circulating 
immunoglobulins in lymphatic filarial infection but shows prominent 
response (Ottesen et al, 1985). Lai and Ottesen (1988a) demonstrated 
that IgG4 antibody detection produce increased specificity for detecting 
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filarial infection, as compared to total IgG, even when crude parasite 
antigen was used. These assays were more specific than assays those 
measures total antibodies to crude antigen-mixture, but they did not 
achieve full species-specificity and also do not correlate the active 
infection. The lack of acceptable specificity and sensitivity of antibody 
detection assays in the serodiagnosis of filarial infections was one of 
the major reasons for the development of antigen detection assays 
(Dissanayake and Ismail, 1987). 
C. Antigen Detection 
The parasite antigen detection is more sensitive and specific for 
diagnosing active filarial infection than parasitological examination or 
antibody detection (Harinath et al., 1984; Forsyth et al., 1985; Weil et 
ai, 1985; 1987; Lai et al., 1987; Anon, 1989). Considerable emphasis 
has been given to the detection of circulating antigen in the blood and 
other body fluids of filarial patients (WHO, 1992; Weil, 1990). The 
antibodies raised against the filarial antigen obtained from infected 
patients have been employed by some investigators for the detection of 
circulating filarial antigen inpatients' sera (Kaliraj et al., 1979; Forsyth 
et al., 1985; Weil et al., 1986; 1988; Weil, 1990; Mustafa et al, 1996). 
Several groups of investigators recently have developed antigen 
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detection assays using polyclonal (Harinath, l984;Kaliraj e?a/., 1979; 
1981; Au ef ai, 1981; Ouaissi et ai, 1981; Hamilton et al., 1984; 
Dasgupta et al., 1984; Weil et al., 1986; Mustafa et al., 1995; 1997) 
and monoclonal (DesMoutis et al., 1983; Dissanayake et al., 1984; 
Forsyth et al., 1985; Weil et al, 1985; More and Copeman, 1990; 
Kaushal et al., 1994a; b; Weil et ai, 1997) antibodies (MoAb) to detect 
filarial circulating antigen. The earlier studies were mainly focussed on 
the antisera raised against somatic extracts of the heterologous filarial 
parasites, i.e. L. carinii (Dasgupta and Bala, 1978; Kaliraj et al, 1981a) 
andZ). /wm/ri5 (Tanabe, 1959; Weil e? a/., 1984a; 1986). 
Circulating filarial antigen was first demonstrated in bancroftian 
filariasis in 1946, using the technique of passive cutaneous anaphylaxis 
(Frank, 1946). The soluble circulating parasite materials has been 
detected by number of workers in W. bancrofti infected individuals 
(Reddy et al, 1984a; b; Zheng et al, 1987b; Lutsch et al, 1987; 
1988; Ramaprasad and Harinath, 1995) and also in patient 
infected with onchocerciasis (Ouaissi et al, 1981; Des Moutis et al, 
1983;Petralandaer al, 1988; Schlie-Guzman and Rivas Alcala, 1989; 
Chandrashekhare/a/., 1990) and thus indicating the active infection of 
filarial parasites. 
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Circulating parasite antigen in patients with bancroftian filariasis 
has been demonstrated using techniques of 'moderate sensitivity' such 
as counter current immunoelectrophoresis and indirect 
heameagglutination test (Kaliraj et ai, 1981c; Au et al, 1981) but 
positive results were obtained only in sera of microfilaraemic positive 
individuals. The CIEP was used for the detection of circulating antigen 
using rabbit anti-filarial sera (Kaliraj et al., 1979a; Dasgupta et al, 
1980; 1984; Das et al, 1988c; Kumar et al, 1991;Dumenigoef a/., 
1993). The antibodies raised in rabbits against L. carinii somatic 
antigen were used for the detection of filarial antigen in human 
patients' sera and it was observed that 5.7% cases diagnosed by 
parasitological examination can be increased to 62.8% by CIEP 
(Dasgupta et al, 1980). The CIEP used to detect the D. immitis 
antigens represents a significant improvement over previously 
available diagnostic techniques because it is more sensitive than 
microfilarial test, and can be related to the active infection and can 
be used as practical diagnostic test for active W. bancrofti infection 
((Kaliraj et al, 1981a; Weil era/., 1984; 1986). The CIEP is simple 
and rapid as compared to IHAT, with increased sensitivity over 
immunodiffusion for the detection of circulating antigen have been 
established in various studies (Krupp, 1974; Dasgupta and Bala, 1978; 
1980; Shariff and Parija, 1991). Hamilton et al, (1984) have used 
antibodies specific for B. malayi adult worms to detect cross-reactive 
antigens in bancroftian filarial pateint by immunoradiometric assay 
32 
(IRMA). Using polyclonal antibodies against adult S. digitata, 
Dissanayake and others (1982) detected antigens in the immune 
complex from bancroftian filariasis patients. The above workers 
detected the antigens in the circulating immune complex 
(CIC) reactive with polyclonal antibodies, but did not assay the 
amount of each antigen. Zheng et al. (1987a), Using polyclonal and 
monoclonal antibodies (E34 and HC 11), have shown filarial antigen 
in 95% of sera from mf donors with bancroftian or brugian filariasis 
and approximately 60% of sera from mf donors and 60% of clinical 
cases by inhibition ELISA using E-S antigen conjugated to 
penicillinase. However, filarial antigen was detected in all the 38 sera 
from mf pateints by CIEP with rabbit antibodies to D. immitis and B. 
malayi (Weil et al, 1986). Recently, 100% positive results were 
reported with mf positive sera by Cheirmaraj et al. (1992) using 
polyclonal antibodies raised in mouse ascites. 
The non-availability of adult W. bancrofti for antigenic 
material, demands the use of antigens from heterologous filarial 
parasites to raise polyclonal antibodies in rabbits and monoclonal 
antibodies for the detection of circulating antigens in filarial infections 
has been employed by several workers (Dasgupta et al., 1980; 1984; 
More and Copeman, 1990; 1991; Kumar et al, 1991; Jaoko, 1995; 
Forsyth et al, 1985; Weil et al, 1984; 1985; 1986; 1987; Maizels et 
al, 1983; 1985b; Kazura et al, 1986; Freedman et al, 1989; Parab et 
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al, 1990; Malhotra et al, 1987; Phillip et al., 1984a; Cabrera and 
Parkhouse, 1986; Egwang and Kazura, 1987; Prasad and Harinath, 
1988; Rajasekhariah et al., 1991; John et al., 1995). Besides these, 
materials from the microfilariae and infective larvae of W. bancrofti 
and of related filarial parasites were also used by a number of 
researchers to produce antisera for the detection of filarial circulating 
antigens in patient sera (Almeida f^ a/., 1990; Reddy et al., 1984b; 
c; Lutsch et al., 1987; Cheirmaraj et al., 1990; 1992; More and 
Copeman, 1991;Dumenigoe/fl/., 1993; Zheng etaL, 1987; Lai 1991; 
Li et al., 1993; Chenthamarakshanera/., 1995; 1996). 
Polyclonal antibodies were raised against somatic extracts of W. 
bancrofti microfilariae, and could detect the filarial circulating antigen 
in microfilaremic positive patient sera (Kaliraj et al., 1979a). Due to 
the use of polyclonal antibodies raised against crude somatic antigens, 
for the detection of circulating filarial antigen, problems of specificity 
and sensitivity remains (Weil, 1990). Therefore, monoclonal 
antibodies have been employed by several investigators for the 
detection of circulating antigen in the filarial infected individuals 
(Dissanayake et al, 1984; Weil et al., 1985; 1987; Forsyth et al., 1985; 
Lai et al, 1987; Weil and Liftis, 1987; Zheng et al, 1987; Santhanam 
et al., 1989; More and Copeman, 1990; Ramzy et al., 1991; Li et al., 
1993; Kaushal et al., 1994; Ramaprasad and Harinath, 1995; Gyapong 
et al., 1998; Lalitha et al., 1998). Assays describing detection of 
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ciculating antigen in onchocerciasis patients were first reported in the 
early 1980s (Ouaissi et al, 1981; Des Moutis et al, 1983) and was 
found to be highly sensitive and specific (Cabrera and Parkhouse, 
1987; More and Copeman, 1990; 1991). Phosphorylcholine (PC) was 
the first truly defined molecules to be targeted in the serum of 
onchocerciasis patients (Weiss, 1985; Maizels et al, 1990). An 
improvement in sensitivity (92.3%) was obtained by Schlie-Guzman 
and RivasAlcala (1989). 
An immunoradiometric assay (IRMA) for the detection of 
filarial antigen was developed using an IgM monoclonal antibody 
(Gib-13) to O. gibsoni egg antigen (Dissanayake et al, 1984; 
Forsyth et al., 1985). The assay detected the parasite circulating 
antigen in 93% and 75% of the sera from amicrofilareamic subjects 
with ^. Z a^/icro/^ z, however, it takes two days to perform the Gib-13 
IRMA. Moreover, as it is an radioimmunoassay, it could not be 
used in field conditions. The Gib-13 shows phosphorylcholine (PC) 
specificity detecting molecules of 140, 52, 56 and 62 kD molecular 
weight and recognizes a carbohydrate moieties. Zheng et al. (1987a; b; 
1990) used monoclonal antibody based sandwich ELISA (sELISA) 
for the detection of circulating filarial antigen using rabbit anti-
microfilarial immunoglobulin as first antibody and monoclonal 
antibodies, against W. bancrofti mf E-S antigen and B. malayi L3 
antigen as second antibody, the positivity rates were 94.5% and 89.0% 
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respectively in microfilareamic patients. Most of the earlier attempts 
to produce monoclonal antibodies against filarial circulating antigen 
have resulted in monoclonals showing reactivity with 
phosphorylcholine epitope and to other, more specific determinants 
(Forsyth et ai, 1985; Lai et al., 1987; Weil et ai, 1987; Zheng et ai, 
1987a; More and Copeman, 1990). The sensitivity of PC assays for W. 
bancrofti infection have ranged from 85 to 93% for sera from 
microfilareamic patients depending upon the population surveyed. PC 
antigenemia has also been detected in sera from patients infected with 
B. malayi (Maizels et al., 1985a). However, the sensitivity of PC 
antigen detection for human B. malayi infections has been very poor. In 
addition, studies on PC antigenemia in filariasis have been reported 
conflicting specificity results. The PC is a widely distributed 
determinant, particularly among the nematode parasites and its 
presence on the filarial parasite antigens may account for much of the 
cross-reacivity observed with other helminth parasites (Maizels et al, 
1987c; Pery et al, 1974; Zheng et al, 1987). Therefore, 
assays detecting the PC determinant is not suitable for the 
specific diagnosis of human filariasis (Forsyth et al, 1985; Lai et al, 
1987; Sutanto et al, 1985). Lai and others (1987) detected a 200 KD 
antigen in the sera of 93% of patients with microfilareamia, 46% of 
those with lymphatic obstruction, and 56% of those with tropical 
pulmonary eosinophilia syndrome using a monoclonal antibody (CA2 
or CAioi) raised against circulating antigen from W. bancrofti. This 
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n;ionoclonal antibody could detect parasite antigen concentration as low 
as 30 to 4000 ng/ml in patients living in an area endemic for 
bancroftian filariasis and it also shows specificity for PC determinants. 
The CAioi monoclonal antibody is an IgMk with the T15 idiotype. 
There are few monoclonal antibodies which are directed against 
non-phosphorylcholine epitopes and are also capable of detecting 
filarial circulating antigen in bancroftian filariasis with minimal or no 
cross-reactivity (Weil and Liftis, 1987; Weil et al, 1987; More and 
Copeman, 1990; Zheng et al, 1990; Kaushal et al, 1994). These 
assays have been successfully used for detecting the filarial circulating 
antigen inpatients' sera (Weil etal., 1988; 1991). Another monoclonal 
antibody (ES 34)) which is against W. bancrofti mf ES antigen (55-63 
kD) has shown promising results in field studies conducted in India and 
China (Zheng et al, 1987; Reddy et al, 1989). But this monoclonal 
could not detect antigen in clinical cases and specificity data was 
insufficient. A specific assay, which is currently 1 undergoing 
commercial development, is based on the monoclonal antibody 
AD12.1 (Weil et al, 1987) which recognises a 200 kD antigen in the 
circulation of individuals infected with W. bancrofti (Weil and Liftis, 
1987) which again is of ES products of adult worm (Weil et al, 1996) 
and is specific for W. bancrofti only (Weil, 1990; Weil ef a/., 1987; 
Ram2y et al, 1991). The monoclonal antibody is of IgGi isotype and 
recognizes the carbohydrate epitopes and detects the absolute 
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amount of protein by a factor of at least 2.4. The sensitivity of 
AD 12.1 assay for sera from microfilareamic patients was 
approximately 95%. The filarial antigen was detected niether in sera 
from non-endemic areas nor from patients with other parasitic 
infections (Reddy et al, 1989). The ICT Filariasis card test is a new, 
rapid-format filarial antigen test based on monoclonal antibody 
AD12.1, was developed by ICT diagnostics (Balgowlah, New South 
Wales, Australia). This assay takes only 5-15 min to complete, requires 
no specialized equipment and gives comparable results (Weil et al, 
1997). 
Another assay that could successfully detect the circulating 
antigen in ELISA is commercially available for detection of W. 
bancrofti infection (Trop-Ag W. bancrofti ELISA kit, JCU Tropical 
Biotechnology Pty Ltd, Queensland, Australia). The assay is based on a 
monoclonal antibody, Og4C3, which curiously, inspite of its being 
raised against antigens of the bovine parasite O. gibsoni, detects 
circulating antigen in serum from W. bancrofti infected patients, but 
not O. vovulus (More and Copeman, 1990) using sandwich ELISA. 
Negative results were also obtained with sera from individuals 
harbouring B. malayi, B. trimori and Loa loa infections. The antigen 
detected in the circulation of bancroftian filariasis patients is of adult 
origin (Chanteau et al, 1994). The monoclonal antibody Og4C3 has 
IgM antibodies. Og4C3 binds to a range of filarial and non-filarial 
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nematodes (O. gibsoni. O. vovulus, D. immitis, A. caninum and 
Toxocara canis) but not to phosphrylcholine. It recognizes antigens of 
M W > 130 kD and 50-60 kD from Og male antigen, with epitopes 
having both protein and carbohydrate moieties. The target antigens of 
Og4C3 are located at the junction of the cuticle, hypodermis, in cells of 
the gut, in intrauterine embryos and extra-uterine microfilariae of O. 
gibsoni. Both assays have been evaluated as diagnostic tools in a 
number of studies (Nicholas, 1997) and can detect circulating antigen 
in virtually all (94-100%) microfilarial carriers (Weil et al., 1987; 
1997; Turner et al, 1993; Chanteau et al, 1994a; b; Rocha et al, 1996; 
Nicholas, 1997). However, most of these MoAbs are of IgM isotypes 
and not very suitable for use in the field test. Kaushal and others 
(1994a) produced MoAb against antigenic epitopes common between 
the bovine (Setaria cervi) and human filarial parasites. The two 
monoclonal antibodies (13B4 and 15D6) that showed reactivity with 
filarial circulating antigen of IgGi isotype and are directed to the 
protien epitope. The target antigen have been cloned using these 
monoclonal antibodies (Kaushal et al, unpublished data). These 
monoclonals showed high reactivity with filarial antigen while very 
little or no reactivity was observed with the non-filarial antigen 
(Kaushal et al, 1994; Kaushal and Kaushal, 1995).This assay has high 
sensitivity but lacks sufficient sensitivity. Ramzy and others (1991) 
evaluated the performance of antigen detection in the sera from an 
endemic area of W. bancrofti in Egypt using MoAb raised against 
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Dirofilaria immitis. They reported that 97% of microfilareamic 
subjects were antigen positive and antigen levels were significantly 
correlated with mf counts. Those methods for detecting circulating 
antigens using MoAbs were reported to have high sensitivities 
correlating with mf counts. 
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SCOPE AND PLAN OF WORK 
Improved methods for diagnosing active filarial infections are 
needed to monitor control efforts and to evaluate new drugs. The most 
commonly used method for the diagnosis of filariasis, is based on 
demonstration of mf in the night blood smears of the patient. This 
test is inconvenient for both the patients as well as the investigator 
emd fails to detect the amicrofilareamic stage of the disease or when 
mf are present in very small numbers or sequestered in the tissues. This 
has put impetus for developing alternate means for filaria diagnosis 
such as immunodiagnostic test. Earlier studies on immunodiagnosis 
of filariasis were focussed mainly on the detection of antibodies, but 
the major shortcoming is their inability to distinguish past exposure 
from current infection. Therefore, in the recent past considerable 
emphasis has been given to the detection of circulating antigen in 
blood or other body fluids of the infected individuals. The 
demonstration of the parasite antigen in circulation of the infected 
individual appears to be an useful indicator of active filarial infection. 
For establishing specific diagnostic techniques identification and 
characterization of parasite-derived antigen is important. Due to the 
complex nature and extensive cross-reactivity of the crude 
somatic antigens with the other nematode parasites, antigens present 
in the excretory-secretory (E-S) products (obtained by the in vitro 
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maintenance of filarial parasites) of these parasites were analysed 
and evaluated for the immunodiagnosis of filariasis. 
Due to the non-availability of human filarial parasite, antigens 
from Setaria cervi (a bovine filarial parasite) have been used in the 
present study. The E-S products were obtained by maintaining S. 
cervi adult worm by short-term in vitro incubation in culture.An 
effort was made to isolate the S. cervi E-S products, raise polyclonal 
antibodies against E-S antigens and this anti E-S antibodies could 
detect the circulating antigen in human filarial patient sera. Therefore, 
the E-S products were fractionated in order to identify the relevent 
antigen (equivalent to the filarial circulating antigen), produce 
polyclonal and monoclonal antibodies and the potential of these 
monoclonal antibodies were evaluated for the detection of circulating 
antigen in human filariasis. 
The present study deals with the following aspects: 
I. Preparation and immunochemical characterization of excretory-
secretory (E-S) products from S. cervi adult worms. 
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II. Raising of polyvalent hyperimmune antibodies against S. cervi 
E-S products in rabbits and its evaluation for the detection of 
circulating antigen in filarial patient sera. 
III. Fractionation of S. cervi E-S products and immunochemical 
characterization of fractionated E-S products and identification 
of antigen equivalent to filarial circulating antigen. 
IV. Production and characterization of polyclonal/monoclonal 
antibodies against the relevent E-S antigens. 
V. Evaluation of the antibodies for the detection of circulating 
antigen in filarial patient sera. 
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CHAPTER II 
MATERIALS 
AND 
METHODS 
PARASITES 
Setaria cervi, a bovine filarial parasite, was collected from the 
peritoneal folds of freshly slaughtered Indian water buffaloes from the 
local abbatoir and brought to the laboratory in normal saline. The 
motile worms (both males and females) were washed thoroughly with 
normal saline to remove all the adhering materials and were used 
immediately for antigen preparation or stored at -20°C until used. 
EXPERIMENT ANIMALS 
Albino rabbits of either sex (weighing 1.5 to 2.0 Kg)and 
BALB\c mice (6-8 weeks old) from the inbred colony of Central 
Drug Research Institute's animal house, were used. All the animals 
were kept in separate cages and fed on balanced diet and housed in an 
air conditioned room. 
CHEMICALS USED 
Acrylamide, agarose, ammonium persulphate, anti-rabbit IgG 
(whole molecule) horse radish peroxidase conjugate, 2-beta 
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mercaptoethanol (PME), bisacrylamide, bovine serum albumin (BSA), 
bromophenol blue, coomassie brilliant blue (R~250), ethylene diamine 
tetra acetic acid (EDTA), hypoxanthine aminopterin thymidine (HAT), 
molecular weight markers, nitrocellulose paper (NCP), orthophenylene 
diamine (OPD), polyethylene glycol (PEG), sodium dodecyl sulphate 
(SDS), N N N'N' tetramethyl ethylene diamine (TEMED), Tris 
(Hydroxymethyl) aminomethane (TRIS Buffer) were procurred from 
Sigma Chemical Company, St. Louis, MO, USA, Freund's complete 
and incomplete adjuvants were obtained from Difco Detroit, MI, USA. 
The CNBr activated sepharose CL-4B was procurred from Pharmacia 
Biotech AB, Uppsala, Sweden. The powdered Dulbecco's modified 
eagle medium (DMEM) was obtained from Gibco Laboratories, NY, 
USA. All other chemicals used were of analytical grade. Triple 
distilled water was used in all the experiments. 
PREPARATION OF ANTIGEN 
The excretory-secretory (E-S) emtigens were prepared by short 
term in vitro maintenance of bovine filarial parasites as described by 
Malhotra et al. (1987). The medium used for the culture was prepared 
by dissolving one packet of Dulbecco's modified eagle medium 
(DMEM), 2.38g of N-2 hydroxylethyl piperazine-N'-2- ethane 
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sulphonic acid (HEPES), 3.8g sodium bicarbonate and 0.3g glutamine 
to make 1 Itr with triple distilled water. This solution is filtered 
through 0.22 |im millipore filter for sterilization and dispensed into 
sterile screw capped flask. 
The adult motile worms (70-75) of S. cervi (both males and 
females) were maintained asceptically at 37°C for 32 hr in a protein 
free defined medium i.e. DMEM containing 1000 U/ml, penicillin and 
100 g/ml streptomycin. The medium was changed at regular intervals. 
The spent medium was centrifuged at 1000 x g (3000 rpm) for 10 min 
to remove the microfilariae released in the medium. The supernatant 
was kept at -70°C until used. The E-S products were concentrated by 
lyophilization. The lyophilized E-S materials were reconstituted in 
minimal volume of normal saline and were dialysed against the 
normal saline. This was again centrifuged at 1000 x g (3000 rpm) for 
10 min and the E-S products finally prepared were stored at -70°C 
until used. 
PROTEIN ESTIMATION 
The protein contents of the E-S products were determined by 
the microassay procedure of Bradford (1976) while the procedure of 
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Lowry's et al. (1951) was used to measure the protein contents of 
somatic antigen and antibodies. 
Bradford's method: prepared several dilutions of 0.8 ml of 
protein standard (BSA 1 mg/ml) from 1 to 25 |a.g/ml and 0.8 ml 
of sample buffer for blank, then 0.2 ml of Biorad dye reagent 
(Biorad, USA, Coomassie brilliant blue in phosphoric acid). It was 
mixed gently and after 5 min optical density (O.D.) was measured at 
595 nm in spectrophotometer. 
Lowry's method: several dilutions of 0.4 ml of protein standard 
(BSA, 500 |J.g/ml) from 10 to 50 |J,g/ml or above were made and 0.4 
ml of sample buffer for blank was taken. To all the samples 2.0 ml 
copper reagent was added (0.5 ml of Na, K, tartarate, 0.5 ml of 1% 
copper sulphate. 5H2O and 50 ml of 2% sodium carbonate dissolved in 
0.1 N sodium hydroxide), incubated for 10 mins 0.2 ml of Folin's 
reagent (IN) was added and the mixture was mixed thoroughly and 
optical density was measured at 625 nm after 30 min. 
SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS 
The SDS-polyacrylamide gel electrophoresis (SDS-PAGE) of 
S. cervi E-S antigen was done according to Laemmli (1970) using 
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Pharmacia slab gel electrophoresis apparatus. A separating gel of 10% 
acrylamide was used. The composition of the mixture was 10 ml of 
stock acrylamide (30%) and bisacrylamide (0.8%)), 7.5ml of 1.5M 
Tris-HCl (pH 8.8), 300 |il of 10% sodium dodecyl sulphate (SDS), 
100 |xl of 10% ammonium persulphate (APS), and 10 j^ l of N N N'N' 
tetra methyl ethylene diamine (TEMED) in a total volume of 30 ml 
made up with triple distilled water. The stacking gel (4.5%) 
contained 1.49 ml of acrylamide stock solution (30% acrylamide and 
1% bisacrylamide), 2.63 ml of 0.5M Tris-HCl (pH 6.8), 0.1 ml of 
10% SDS, 75 |il of 10% APS and 10 |il of TEMED in a total volume 
of 10 ml made up with distilled water. The samples were prepared by 
mixing equal volumes of the E-S antigen with SDS-PAGE sample 
buffer (containing 12.5 ml of IM Tris-HCl buffer, pH 6.8; 20 ml of 
glycerol; 10 gm of SDS; 2 ml of 0.1% bromophenol blue; 10 ml of 
2P-mercaptoethanol (PME) in a total volume of 100 ml) in 1:1 ratio 
and keeping for 5 min in boiling water bath. 
Electrophoresis was carried out at a constant current of 25 mA 
per gel for about 4-5 hr till the tracking dye has reached 1 cm above 
the bottom of the gel. After electrophoresis, the gel was stained with 
0.25% coomassie brilliant blue R~250 (dissolved in 30% methanol 
and 10% acetic acid) and destained with 30% methanol and 7% 
acetic acid. The gel was also stained by silver staining method (Merril 
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et al, 1981). Briefly, the gel was fixed with 50% methanol and 12% 
acetic acid, excess SDS was removed by washing three times with 200 
ml of 10%) ethanol and 5% acetic acid. The gel was soaked for 10 
min in 200 ml of 0.0034 M potassium dichromate and 0.0032N nitric 
acid. The gel was then washed 4 times with 200 ml of distilled water 
and placed in 0.2% silver nitrate solution for 30 min. The gel was 
again washed twice with distilled water, followed by rapid staining 
with two 300 ml of the image developing solution, containing 0.28 M 
sodium carbonate and 0.5 ml formalin per Itr. Gel was gently 
agitated in a third portion of the developing solution until the image 
has reached the desired intensity. The reaction was stopped by 
putting the gel in 100 ml of \% acetic acid. 
IMMUNIZATIONS 
Rabbits 
The poljrvalent hyperimmune serum against the S. cervi E-S 
antigens were raised in albino rabbits of either sex. The rabbits were 
immunized intramuscularly with an emulsion of 0.5 mg of 5. cemE-
S product in Freund's complete adjuvant. One month after the first 
injection, three subsequent injections were given at seven days 
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interval with E-S products emulsified in Freund's incomplete adjuvant. 
The rabbits were bled one week after each injection starting from third 
injection. The serum was obtained by centrifugation of blood at 900 
X g (2500 rpm) for 10 min. The immunization and bleeding of 
rabbits were continued and done alternatively at 15 days interval in 
order to get the hyperimmune sera. The serum obtained was stored at -
20°C until used. Similarly rabbits were immunized with bovine serum 
albumin (BSA, 2mg/rabbit) in order to raise the hyperimmune sera 
against BSA. 
ENZYME LINKED IMMUNOSORBENT ASSAY 
Enzyme linked immunosorbent assay (ELISA) was performed 
according to Voller et al. (1974), with few modifications, in a 96 
well polystyrene plates. Briefly, the microtitre ELISA plate was 
coated with different concentrations of S. cervi E-S antigens (7.5 ng-
1000 ng/well) diluted in phosphate buffered saline (PBS, 0.05M, 
containing 0.04M disodium hydrogen phosphate, 9.5mM sodium 
dihydrogen phosphate, and 0.15M sodium chloride, adjusted to pH 
7.4) and incubating the plate for 18-20 hr at 37°C. The plate was 
washed thrice with PBS to remove the unbound antigen. The 
uncoated sites of the plate were blocked with 5% non-fat dry milk in 
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PBS for 2 hr at 37°C. The plate was washed thrice with PBS containing 
0.05% Tween-20 (PBS-Tween). Then, the plate was incubated with 
100 ml of fixed dilutions of antibody to each well and kept for 2 hr at 
37°C. Again the plate was washed with PBS-Tween and then 
incubated with peroxidase conjugated secondary antibody at 1:1000 
dilution in 1% milk for 90 min at 37°C. Finally, the plate was washed 
with PBS-Tween and was developed with substrate i.e. 
orthophenylene diamine (OPD Img/ml) in 0.05M citrate buffer 
(0.02M citric acid and 0.05M disodium hydrogen phosphate), pH 
5.2, containing hydrogen peroxide (H2O2, 1 jil/ml). The reaction was 
stopped after 10 min with 5N H2SO4 and the colour intensity was read 
at 490 nm in an ELISA reader. 
CROSSED IMMUNOELECTROPHORESIS 
Crossed immunoelectrophoresis (CIE) was performed according 
to Axelsen et al. (1973). The S. cervi E-S antigens were separated in 
1.5 mm thick layer of 1% agarose in 0.02 M barbital buffer, pH 8.6 (20 
mM diethylbarbituric acid, 80 mM Tris, 20 mM sodium azide, 0.8 mM 
calcium lactate) for 1 hr at a constant voltage of 150 V. After 
separation in the first dimension, 1x6 cm agarose strip containing the 
separated antigens was transferred to another plate (6x9 cm). Anodic 
51 
(5x6x0.12 cm) and cathodic (2x6x0.12 cm) gel containing 5-10% 
immune rabbit serum was poured onto the plate. An intermediate 
gel (1x6x0.13 cm) containing no antibody, was poured between the 
anodic gel and the first dimension gel containing the separated antigen 
strip. The plate was electrophoresed at right angle to the first 
dimension for 18-20 hr at 2-3 V/cm. The CIE plate was washed three 
times with isotonic saline for 45 min each and finally with distilled 
water for 15 min and alternate pressing of the plate was done under 
several sheets of filter paper. The plate was air dried, stained with 
0.25% w/v of commassie brilliant blue (R~250) made in 45% ethanol 
and 10% acetic acid and destained with the same. 
CROSSED LINE IMMUNOELECTROPHORESIS 
Crossed line immunoelectrophoresis (CLIE) is the modification 
of CIE and was carried out in the similar manner except that in 
CLIE the test antigen (50-100 |j,g) was introduced into the 
intermediate gel. After electrophoresis the plate was washed and 
stained as described earlier for CIE. On staining, the common antigen 
gave a line at the base of the antigenic peaks. 
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TANDEM CROSSED IMMUNOELECTROPHORESIS 
Tandem crossed immunoelectrophoresis (tCIE) is almost similar 
to that of CIE and is carried out in the same manner except that in 
tCIE the test antigen was mixed with the antigen (1:1 ratio) and 
electrophoresed togather in the first dimension. The second 
dimension electrophoresis is similar to that of CIE. After 
electrophoresis the plate was washed, dried and stained as described 
earlier in CIE. On staining the common antigen showed the increase 
in height of the precipitin peaks as compared with the control CIE. 
ABSORPTION OF S. CERVIE-S PRODUCTS ON ANTI-BSA y-
GLOBULIN SEPHAROSE 
The anti-BSA sera raised in rabbits were used to prepare y-
globulin fraction by ammonium sulphate fractionation method. The 
anti-BSA y-globulin fraction was coupled to cyanogen bromide 
activated sepharose CL-4B (Pharmacia) as follows: 100 mg anti-BSA 
y-globulin fraction was mixed with 10 ml of the preswellon sepharose 
CL-4Bin 45 ml coupling buffer (0.1 MNaHCOs and 0.5M NaCl, pH 
8.3) by shaking end over end overnight at 4°C. The unbound 
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protein was removed by washing the beads with Tris-HCl buffer (pH 
8.0) and the residual active groups were blocked with IM 
diethanolamine (pH 8.0), overnight at 4°C. The sorbent was washed 
alternatively with 0.1 M acetate buffer (IM NaCl, 0.012 M sodium 
acetate.BHaO and 0.096M glacial acetic acid), pH 4.0, and 0.1 M 
borate buffer (0.1 M boric acid, 0.025 M sodium tetraborate and 0.075 
M NaCl), pH 7.9, with 10 min. minimum exposure to each buffer. 
Finally, the sorbent was stored in 0.005M borate buffer containing 
0.15 M NaCl, pH 8.0, having 0.01% sodium azide. 
For the absorption, one ml of S. cervi E-S products were mixed 
with 2 ml oftheanti-BSAsepharosebeadsand was rocked gently for 
24 hr at 4°C, centrifiiged and taken out. Again the preabsorbed E-S 
products were mixed with 1 ml anti-BSA sepharose beads and 
rocked gently for 8 hrs at 4°C, centrifiiged and taken out. This 
preabsorbed E-S products were stored at -70°C until used. 
ABSORPTION OF RABBIT ANTI-5^ . CERVI E-S SERUM WITH 
BOVINE SERUM ALBUMIN-SEPHAROSE 
The bovine serum albumin (BSA) was coupled to cyanogen 
bromide activated Sepharose CL-4B (Pharmacia) as follows: 5 mg 
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BSA was conjugated to 1 ml moist gel in 45 ml coupling buffer (0.1 M 
NaHCOa containing 0.5M NaCl, pH 8.3) by shaking end over end at 
25±2°C for 2 hr. Unbound protein was removed by washing the 
sorbent with Tris-HCl buffer (pH 8.0) and residual active groups 
were blocked by incubation with IM diethanolamine (pH 8.0) for 2 hr 
at 25±2°C. Excess diethanolamine was removed by alternate 
washing of sorbent with 1% ammonium bicarbonate (0.1 M, pH 8.0) 
and 0.1 M acetate buffer, pH 4, containing NaCl (0.5 M) with 10 min 
minimum exposure to each buffer prior washing. One and a half ml of 
cmti-S. ccm E-S serum was mixed with 1 ml of BSA-Sepharoseand 
0.5 ml serum was taken out after centrifiigation (unabsorbed). The 
beads were mixed, rocked gently for 1 hr at 25±2°C, centrifuged and 
serum was again taken out (absorbed). The beads were washed three 
times with borate buffered saline pH, 8.4, and bound antibodies were 
eluted with 0.2 M glycine, pH 2.8, and immediately neutralized with 
2.0 M Tris-HCl, pH 8.0. The eluted antibodies were dialysed and 
concentrated to 1.0 ml (eluted). Both the absorbed and eluted 
antibodies were stored at -20°C until used. 
COUNTER CURRENT IMMUNOELECTROPHORESIS 
The counter current Immunoelectrophoresis (CIEP) was 
performed according to Siber and Skapriwsky (1978) by pouring 1% 
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agarose, w/v (1.5 mm thick) on a glass plate. Parallel rows of wells 2 
mm in diameter and 5 mm apart were punched out on the glass plate 
with the aid of a template. Each well was filled with five microlitre of 
patient sera and 10 |al of rabbit anti-E-S serum. Wells containing 
antisera were placed on the anodic side of the electrophoretic chamber, 
those containing the antigen on the cathodic side. Electrophoresis 
wasperformedataconstantvoltageof 100 volts for 30 min. The plate 
was placed in a moist chamber at 37°C for 1 hr. The CIEP plate was 
read unstained immediately after incubation with the use of oblique 
lighting against a dark background. The plate was then placed in 
normal saline overnight at room temperature. The plate was washed, 
dried and stained similarly as described previously in CIE. Positive 
reactions were defined by precipitation lines between antigen and the 
sera. Positive and negative controls were included with each test. 
FRACTIONATION OF S. cervi E-S PRODUCTS USING DEAE-
SEPHACEL COLUMN 
A DEAE-Sephacel (Pharmacia) anion exchange column was 
prepared having a bed dimension of 2x25 cm and was equilibrated 
with 20mM Tris-HCl, pH 7.5. The S. cervi E-S products (5 mg 
proteins) was applied to the DEAE-Sephacel column. The unabsorbed 
56 
E-S protem was removed by passing 20 ml of 20mM of Tris-HCl, pH 
7.5. The absorbed E-S products were eluted by a linear chloride 
gradient formed from 20 ml of starting buffer (20mM Tris-HCl, pH 
7.5) and 20 ml of lOOmM sodium chloride, 250mM NaCl and 500mM 
NaCl gradient.Fractions were collected of 3 ml volume at a flow rate of 
1 ml/5 min and the absorbancy of the fractions was measured at 280 
nm in a double beam spectrophotometer (Shimadzu). The fractions 
were tested in ELISA against the anti-E-S rabbit antibodies and the 
monoclonal antibodies. 
HYBRIDOMA PRODUCTION 
Immunization of mice 
The BALB/c mice from the animal facility of Central Drug 
Research Institute, Lucknow (India) were immunized by subcutaneous 
(s.c.) injection of 20 |ig S. cervi E-S purified antigens emulsified in 
Freund's complete adjuvant. Second injection was given at 15 days 
interval after the first antigen. The mice were bled on 7**^  day from the 
second injection and was tested for antibody to S. cervi E-S product by 
enzyme linked immunosorbent assay (ELISA). The mice chosen for 
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fusion were boosted with 20 \ig of S. cervi E-S products and were 
immunized intervenously 4 days before fusion. 
Fusion 
The fusion was performed according to Kohler and Milestein 
(1975), Briefly, the mice were sacrificed and the spleen cells were 
taken out. The spleen cells and the myeloma cells were washed twice 
with DMEM before fusion and was centrifuged at 200xg for 5 min. 
The erythrocytes present in the spleen cells were lysed with 0.9% 
ammonium chloride. The viability of the cells was checked by trypan 
blue exclusion and the cells were counted in haemocytometer. The 
spleen cells from the immune mice were fused with sp2/0 myeloma 
cells (in a ratio of 1:10) with the addition of 1 ml polyethylene glycol 
(PEG, mol. wt. 1500) in 1 min and were cultured in a hypoxanthine 
aminopterin thymidine (HAT) selection medium in 24 well culture 
plates. 
GROWTH IN HAT SELECTION MEDIUM 
The pellat was suspende in hypoxanthine-aminopterin-thymidine 
(HAT, 13.6 mg/ml hypoxanthine, 0.019 mg/ml aminopterin and 0.388 
mg/ml thymidine) medium with 10% FCS-supplemented DMEM. The 
suspension was diluted to 2x10^ cells/ml and immediately 1.0 ml of 
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this was aliquoted into the wells of costar, 24 well culture plates. The 
plates were kept in humified atmosphere, 5% CO2 incubator at 37°C. 
Next day half of the medium was replaced with fresh HAT selection 
medium and the growing hybrids were identified by visible colonies in 
an inverted phase contrast microscope. 
HYBRIDOMA SCREENING PROCEDURE 
The cell culture supematants were initially screened for anti-
filarial antibodies to S. cervi E-S products in ELISA. After few days of 
regular screening, once the positivity of the wells was established, they 
are subjected to growth in HAT selection medium. The positive wells 
were cloned twice, by limiting dilution techniques in a 96 well 
microtitre plate to ensure the monoclonality. The positive wells in each 
cloning were screened by ELISA. Subsequently, the clones, secretory 
anti-filarial antibodies were grown in DMEM cotaining 10% FCS, in a 
25 cm^ tissue culture flasks. 
MONOCLONAL ANTIBODY PRODUCTION AND 
PURIFICATION 
The hybridomas were maintained in cultures and the supernatant 
collected was stored at -20°C. The Ig globulin fractions were isolated 
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from supernatant by 45% ammonium sulphate precipitatoin method. In 
between the cells were detracted from the culture and were injected i.p. 
to pristaned (Sigma) primed BALB/c mice for ascites production after 
10 days the ascitic fluid was formed and this was collected by bleeding 
the mice. The ascitic fluid was centrifuged at 800xg for 30 min to 
remove the cellular materials and the supernatant collected was 
aliquoted and stored at -70°C until used. 
The Ig globulins were isolated from ascitic fluid by 45% 
ammonium sulphate precipitation and was left overnight at 4°C. The 
precipitate was collected after centrifiigation at 10 000 g for 20 min 
the pellat was solubilised in 0.15M NaCl and was dialysed against it 
and kept at -70°C until used. Further purification of IgG monoclonal 
antibodies were achieved by batch wise freatment with protien-A 
Sepharose (Pharmacia) column in 0.05M Tris-HCl with 0.05M NaCl, 
pH 8.2. The bound IgGs were eluted at pH values between 6-3, which 
is characteristic of their subclass (Ey et al., 1978). Briefly, to 100 ml 
culture supernatant add 5ml of IM Tris-HCl, pH 8.2. At room 
temperature pass the supernatant slowly over a column containing 1ml 
protein-A Sepharose was swollen and washed in 0.05M Tris-HCL pH 
8.2 containing 0.15M NaCl. The column was washed with 10 ml of the 
previous buffer and elution was done with 4ml of 0.05 M sodium 
citrate ,pH .5 containing 0.05 M NaCl into 2 ml of IM Tris-HCl, pH 
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8.2 to raise the pH. The eluate was dialysed against 0.05M Tris-HCl, 
pH 8.2 and was stored in aliquotes at -70°C. The protein-A Sepharose 
column was recovered by washing with 10 ml of 0.05M Tris-HCl 
containing 0.15M NaCl, pH 8.3 and can be reused. 
INfflBITION ELISA 
The inhibition ELISA was done according to Stahli et al. (1983). 
The microtitre polyvinyl plates were coated with 0.25 mg/well S. cervi 
E-S purified antigen overnight at 37°C. The plate was washed with 
PBS. The uncoated sites were blocked by 5% non-fat dry milk in PBS 
(w/v) for 2 hr at 37°C. The plates were washed with PBS-Tween. 
Wells were then exposed with two fold dilutions of purified antigen 
and increasing concentration of monoclonal antibodies at 37°C for 2 
hr. After washing the plate was incubated with anti-mouse horse 
radish peroxidase for 1 Vi hr at 37°C and finally developed with OPD 
as done in ELISA above and the reaction was stopped after 10 min 
with 5N H2SO4 and OD was read at 490 nm in an ELISA reader. 
SANDWICH ELISA 
The sandwich ELISA was done as described by Zheng et al. 
(1987) with few modifiations. Briefly, the wells of microtitre plates 
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were coated with 100ml of rabbit anti-S. cervi E-S IgG (20mg/ml) in 
PBS, pH 7.4 by keeping at 37°C for 3 hr. The plate were blocked by 
incubation with 5% non-fat dry milk in PBS (PBS-milk) for 2 hr at 
37°C. After washing the plates with PBS-Tween (PBS containing 
0.05% Tween 20). 100 ml of 1:1 diluted filarial patient sera or serum 
pool (pool of 10 filarial patient sera positive for circulating antigen in 
coimter immunoelectrophoresis with rabbt anti-E-S serum) or normal 
human sera or serum pool were added to the wells and incubated at 
37°C for 3 hr. The culture supematants (100 ml) from different 
hybridoma clones were added to the wells and incubation was done 
overnight at 4°C. The plates were washed with PBS-Tween, incubated 
at 37°C for 90 min with peroxidase conjugated rabbit anti-mouse Ig 
(1:2500 in PBS-milk Tween) and developed as described for ELISA. 
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CHAPTER III 
RESULTS 
AND 
DISCUSSIONS 
RESULTS 
Filariasis is a serious health problem in the tropical and sub 
tropical countries. The only definite method for the detection of 
filariasis is the presence of microfilariae in the blood of the infected 
individuals. This method is inconvenient due to the nocturnal 
periodicity of the microfilariae and often fails to detect the disease 
when microfilariae are present in less numbers and/or hidden in 
tissues. Therefore, immunodiagnosis based on antibody/antigen 
detection has been found to be a major challenge for the diagnosis of 
human filariasis. The antibody detection method, employing crude 
somatic extracts, showed extensive cross-reactivity with antigens from 
other helminth parasites and are not able to discriminate past and 
present infections. Detection of circulating antigen in bancroftian 
filariasis has been shown to be a useful tool for the conformation of an 
active infection. The characterisation of parasite derived antigens 
would be helpful for identifying the diagnostically important antigens 
and also for developing specific diagnostic reagents for human 
filariasis. The excretory-secretory antigens are comparatively less 
complex in nature and more specific in defining infection than crude 
somatic antigens. Therefore, the present study was undertaken on the 
identification and characterisation of the excretory-secretory (E-S) 
products, from the adult bovine filarial parasites, Setaria cervi. The 
antibodies (polyclonals and monoclonals) against E-S products were 
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also evaluated for their potential in detecting the filarial circulating 
antigen in patients' sera. 
I. PREPARATION OF S. CERVI EXCRETORY-
SECRETORY PRODUCTS AND PRODUCTION OF 
POLYCLONAL ANTIBODIES 
I. Preparation and protein analysis of the S. cervi E-S products 
The S. cervi E-S products were prepared by in vitro maintenance 
of adult worms (both males and females) in a protein free defined 
medium i.e. DMEM (Dulbecco's modified eagle medium) for 32 hr at 
37°C imder asceptic conditions. The incubation medium was changed 
at regular intervals and fresh medium was added. The spent medium 
was centrifiiged at 3000 rpm (lOOOxg) for 10 min., to remove the 
microfilariae released in the medium, and was kept at -70°C until 
lyophilization. The medium was concentrated by lyophilization and 
was reconstituted with minimum volume of normal saline and was 
dialysed extensively against the normal saline. The dialysed E-S 
products were kept frozen in small aliquotes until used. The protein 
content of the S. cervi E-S products was found to be 12-15 mg/100 
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Fig. 2: SDS-polyacrylamide gel electrophoretic analysis of 
Setaria cervi excretory-secretory products. 
A: Somatic antigen B: Excretory-secretory products 
TOP is the point of application and B(j)B is dye marker 
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adult worms The protein pattern of the S. cervi E-S antigen was 
analysed on SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
along with the S. cervi adult somatic antigens. Out of the different 
concentrations of the gel tried, 10% of the polyacrylamide gave the 
best resolution. The SDS-PAGE pattern of the E-S antigen is shown in 
Fig. 2. The S. cervi E-S product showed the presence of 14-15 
protein bands, whereas, the adult somatic antigen showed 35-40 
protein bands. Standard molecular weight markers were used in order 
to determine the molecular weights. The protein bands of the E-S 
product lie in the molecular weight range of 10-200 kD with major 
protein bands in low molecular region (10-70 kD). 
II. Immunization of rabbits with S. cervi E-S products and 
quantitation of parasite specific antibodies immune sera 
The immunization ofthe rabbits with 5. cem E-S products was 
done in order to raise hyperimmune rabbit sera. Three rabbits (R-1, 
R-2 and R-3) were immunized intramuscularly for a period of 6-7 
months. The immune sera were collected from these rabbits after 
each injection and tested in enzyme linked immunosorbent assay 
(ELISA) for parasite specific antibodies. ELISA was standardised in 
terms of optimum antigen concentration, antibody conjugate and 
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dilutions of antiserum. Different concentrations of S. cervi E-S 
products (1, 0.5, 0.25, 0.125, 0.062 and 0.03 i^ g per well) were 
tried using hyperimmune sera at a fixed dilution. The immune sera 
from 3 rabbits gave comparable antigen titration curve as shown in Fig. 
3. Out of the different antigen concentrations, 0.25 \i% concentration 
of S. cervi E-S product was found to be optimum (Fig. 3). The 
optimum antibody conjugate was previously standardised in the 
laboratory by using different dilutions of antibody enzyme conjugate 
(1:250,1:500,1:1000 and 1:2000). The 1:1000 dilution of antibody 
conjugate was found to be optimum. The other assay conditions such 
as the optimum orthophenylene diamine (OPD) and hydrogen 
peroxide (H2O2) were also previously standardised in our laboratory 
and found to be Img/ml OPD and l|il/ml H2O2. 
The optimum antigen concentration (0.25 j^g/well) and 1:1000 
dilution of antibody conjugate were used further in all the 
experiments for determining the antibody titres of the three immune 
rabbit sera. The immune rabbit sera from the three rabbits (immunised 
against ScES), collected after different injections (starting from Iir** 
injection to the last injection) were tested in ELISA at different 
dilutions. Though, the antibody titre was found to be increasing upto 
the 8* injection in the sera of rabbits 1 and 3 and after that it became 
constant, while the antibody titre of immune serum from rabbit 2 
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O.D. t t 490 nm 
3.000 
2,000 -
1.000 
0.000 
0.016 0.031 0.062 0.126 0.26 
Antlgin concantratlon (up/mil) 
0.60 1.0 
Fig. 3:0ptimum antigen concentration of 5. cervi excretory-
secretory products using immune rabbit sera from three rabbits. 
IRS 1: Immune rabbit sera I 
IRS 2: Immune rabbit sera 2 
IRS 3: Immune rabbit sera 3 
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Table 1: Antibody titre of rabbit anti-5. cervi E-S serum 
obtained after different injection in ELISA using excretory-
secretory products 
Number 
of 
Injections 
3rd 
4th 
S''' 
6'*' 
/yth 
gth 
9th 
10"' 
Pooled 
serum 
IRSl 
1:8000 
1:16000 
1:32000 
1:64000 
1:64000 
1:128000 
1:128000 
1:128000 
1:128000 
IRS2 
1:16000 
1:32000 
1:64000 
1:64000 
1:128000 
1:128000 
1:256000 
1:256000 
1:256000 
IRS3 
1:16000 
1:32000 
1:64000 
1:128000 
1:128000 
M:256000 
1:256000 
1:256000 
1:256000 
300-
260 
200 
150 
100-
60 
Reciprocal antibody titrs 
linsi IRS2 CZDiRsa 
1 i| " i " I " i " I 
n n 
- f4 
3 6 7 9 11 3 5 7 9 11 3 6 7 9 11 
8«ra after different injectlona 
Fig. 4: Titration of anti-5. cervi E-S serum after different 
injection for parasite specific antibodies. 
O.D. at 490 nm 
600 1000 l«000 138000 S13000 10000000 
Reciprocal antibody dlltitloni 
Fig. 5:Titration of rabbit anti-^. cem E-S serum pool for 
parasite specific antibodies against S. cervi E-S products in 
ELISA 
showed increasing trends upto 9* injection. The immune rabbit serum 
1 (IRS 1) showed lower antibody titres as compared to IRS 2 and IRS 
3 (Fig. 4). The titres of parasite specific antibodies in sera of three 
rabbits collected after different injections are given in Table 1. 
The immune rabbit sera showing the same titre values were 
pooled separetly for each rabbit. The pooled rabbit anti-ScE-S serum 
from rabbit 1 (IRS 1) showed reciprocal antibody titre of 128 000 
whereas, reciprocal antibody titre of 256 000 as obtained for sera 
from rabbit 2 (IRS 2) and rabbit 3 (IRS 3). On titrating the immun 
rabbit serum pools, parallel titration curves were obtained for the 
three rabbits, however, IRS 1 gave lower ELISA values (Fig. 5). 
II. IMMUNOCHEMICAL CHARACTERIZATION OF S. 
CERVIE-S PRODUCTS 
i. Crossed immunoelectrophoretic analysis ©f S..cervi E-S 
products 
The antigenic analysis of the S. cervi excretory-secretory products 
were done by immunochemical techniques such as crossed 
10 
immunoelectrophoresis using hyperimmune rabbit anti-E-S sera. The 
S. cervi E-S products were analysed by two dimensional gel 
electrophoresis or crossed immunoelectrophoresis (CIE), in order to 
get a better resolution of the antigenic components. Different 
concentrations of the rabbit anti-E-S serum (2.5%, 5% and 10%) were 
tried in CIE. The number of precipitin peaks remained same in all the 
three concentrations but greater resolution ofthe peaks were found in 
10% serum concentration in the sera from rabbit 1 while the sera from 
rabbits 2 and 3 gave optimum results with 5% serum concentration. The 
hyperimmune rabbit anti-ScES serum pools was also used to analyse 
the S. cervi E-S products in CIE and gave 10 precipitin peaks with 
immune rabbit serum pool 1 (R-1). However, 11-12 precipitin peaks 
were seen with immune serum pool 2 (IRS 2) and 3 (IRS 3) 
respectively (Fig. 6). 
The rabbit anti-ScE-S serum was evaluated for the detection of 
circulating antigen in filarial patients' sera using counter current 
immunoelectrophoresis (CIEP). The rabbit anti-ScE-S serum detected 
the circulating filarial antigen in patient serum pool (pools of the 
microfilareamic positive patient sera), but also showed non-specific 
reaction with normal human serum (Fig. 7). This may be due to the 
presence of host serum proteins in the S. cervi E-S products. Therefore, 
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Fig. 7: Counter current immunoelectrophoretic analysis 
for the detection of filarial circulating antigen using 
pooled anti-iS". cervi E-S serum. 
NHS: Normal human serum 
Pt. Pool: Patient pooled serum 
IRS pool: Immune rabbit serum pool. 
efforts were made to identify and remove this non-specificity from the 
S. cervi E-S products 
i. Identification of host serum proteins present in the S. cervi 
E-S products 
Since adult worms of S. cervi resides in the peritoneal folds of 
the infected host, there is possibility of adsorption of host serum 
proteins by the parasite and subsequent excretion of these host proteins 
during in vitro incubation of adult worms for preparing the E-S 
products. In order to detect the presence of the host serum proteins, the 
S. cervi E-S products were analysed in CIE using rabbit antibodies 
against normal buffalo serum (NBS), previously prepared in the 
laboratory. The results showed the presence of 3-4 precipitin peaks 
(Fig. 8),which indicates the presence of host serum components in 
the E-S products. Further, identification of the host serum proteins 
were done by raising hyperimmune serum against BSA in rabbits. The 
anti-BSA serum was used to analyse the E-S products and this 
showed 3 precipitin peaks in S. cervi E-S products, of which one^at,^ 
dark precipitin peak (Fig. 9A). The bovine serum albumin (BSA) was 
also used in CIE against the rabbit anti-E-S serum and this revealed the 
presence of 2 precipitin peaks (Fig. 9B), thus indicating the host serum 
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Fig. 8: Crossed immunoelectrophoretic pattern of 5. cervi 
excretory-secretory products using normal buffalo serum. 
Arrow indicates the point of application of antigen. 
Anode (+) is to the right in the first dimension and at the top in 
second dimension 
B 
^ 
+ 
Fig. 9: Crossed immunoelectrophoretic pattern of S^. cervi E-S 
products using anti-BSA serum (A); and BSA using anti-ScE-S 
serum (B). * 
Arrow indicates the point of application of antigen. 
Anode (+) is to the right in the first dimension and at the top in 
the second dimension 
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contaminants in the S. cervi B-S products. In order to confirm the 
above results, modified crossed immunoelectrophoretic techniques 
were used such as crossed hne immunoelectrophoresis and tandem 
crossed immunoelectrophoresis. Crossed line immunoelectrophoresis 
(CLIE) is similar to CIE except that 50 \ig of BSA was introduced in 
the intermediate gel and this gave precipitin line at the base of two 
precipitin peaks of the E-S products when tested against rabbit anti-S. 
cervi E-S serum (Fig. 10A). Another CLIE was done using E-S 
products against anti-E-S serum and 5% rabbit anti-BSA serum was 
introduced in the intermediate gel and this showed the reduction of 
two precipitin peaks (Fig. 1 OB). 
Another modification of CIE used was tandem crossed 
immunoelectrophoresis (TCIE).This is similar to CIE except that in 
the first dimension. BSA was mixed along with the S. cervi E-S 
products and electrophoresed together, and run against rabbit anti-E-S 
serum in the second dimension. Out of the 12 antigenic components 
of the E-S products two precipitin peaks showed considerable 
increase in the height of the peaks as seen in Fig. 11. These two 
antigenic components are the same as seen in all the three cases 
discussed above i.e. CLIE, TCIE and CIE of BSA thus indicating the 
presence of BSA as one of the major host protein contaminant of the 
S. cervi E-S products. 
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Fig. 10: Crossed line immunoelectrophoretic pattern of 5. cervi 
E-S products using anti-ScE-S serum with intermediate gel 
containing BSA (A) and anti-BSA serum (B). 
Arrow indicates the point of application of antigen. 
Anode (+) is to the right in the first dimension and at the top in 
the second dimension. 
79 
B 
4-
+ 
.M 
t 
+ 
T 
+ 
Fig. 11: Tandem crossed immunoelectrophoretic pattern of S. cervi 
E-S products and BSA (A) and crossed immunoelectrophoretic pattern 
Of 5. cervi E-S products (B) using rabbit anti-E-S serum. 
Arrow indicates the point of application of antigen. 
Anode (+) is to the right in the first dimension and at the top in the 
Second dimension 
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iii. Removal of host serum proteins 
t 
An effort was made to remove the host serum components major 
BSA present in the S. cervi E-S products, by using anti-BSA sepharose 
sorbent. The preabsorbed ScE-S products were analysed for the 
protein pattern in SDS-PAGE and this showed the removal of a major 
protein band of 66 kD present in the S. cervi E-S products (data not 
shown), which corresponds to the bovine albumin band of the 
molecular weight markers. 
Further, the preabsorbed ScE-S products were analysed in CIE 
using anti-E-S serum. Two major antigenic peaks (detected as host 
serum albumin earlier in Fig. 11) were found missing in the 
preabsorbed E-S products. The preabsorbed ScE-S products were 
found to contain 10 precipitin peaks, whereas, in the unabsorbed 12 
precipitin peaks were present (Fig. 12 and Table 2). 
The parasite specific antibodies in the anti-E-S serum was 
quantitated by ELISA using preabsorbed S. cervi E-S products. 
The preabsorbed E-S products gave a parallel curve with the 
unabsorbed ScE-S products (Fig. 13), but the reciprocal antibody 
titre of the absorbed ScE-S product was found to be 120 000 while the 
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Fig. 12: Crossed immunoelectrophoretic pattern of S. cervi 
E-S products after (A) and before (B) absorption on anti-BSA 
Sepharose. 
Arrow indicates the point of application of antigens. . 
Anode (+) is to the right in the first dimension and at the top 
In second dimension. 
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O.D. at 490 nm 
3.00 
2.00 
1.00 
0.00 
' Unabtorbtd ~f~ Abtorbtd 
SOO 1000 
Reciprocal antibody dilutions 
Fig. 13: Antibody titration of rabbit anti-E-S serum using 
Unabsorbed and absorbed S. cervi excretory-secretory products 
on anti-BSA sepharose beads in ELISA. 
*Means of results in triplicate 
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Table 2: Summary of the crossed immunoelectrophoretic 
analysis and enzyme linked immunosorbent assay of the 
absorbed and unabsorbed S. cervi excretory-secretory products 
using rabbit anti-E-S serum. 
Assays 
CIE 
(Number of 
Precipitin bands) 
ELISA 
(Reciprocal 
Antibody titres) 
Absorbed E-S 
products 
10 
120 000 
Unabsorbed 
E-S Products 
12 
250 000 
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iinabsorbed ScE-S products gave a reciprocal antibody titre of 256 000 
summarised in Table 2. 
Similarly, the anti-S. cervi E-S antibodies were absorbed onto 
BSA-Sepharose in order to remove the antibodies against the host 
serum components. The analysis of the preabsorbed anti-E-S serum in 
CIE using ScE-S antigen showed the presence of 10 precipitin peaks, 
(using 5% concentration in both absorbed and unabsorbed anti-E-S 
serum) as compared to 12 precipitin peaks in the unabsorbed ScE-S 
products (Fig. 14). Further quantitation of the preabsorbed anti-E-S 
products was done by ELISA using S. cervi E-S products. Both the 
sera gave parallel curves and the antibody titre of the absorbed anti-E-S 
serum was found to be 1:120 000 and that of unabsorbed E-S products 
gave antibody titre of 1:250 000 (Fig. 15). 
iv. Potential of anti-E-S serum for detection of circulating 
antigen in filarial patient sera using CIEP 
The preabsorbed anti-E-S serum was used to detect the 
circulating filarial antigen in the patient pooled serum (pools of the 
microfilareamic positive patients' sera) by using CIEP. The 
preabsorbed anti-E-S serum gave no cross-reactivity with the normal 
human serum, whereas, successfully detected the circulating antigen 
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Fig. 14: Crossed immunoelectrophoretic pattern of 5. cervi 
Excretory-secretory products using absorbed (A) and unabsorbed 
(B) rabbit anti-E-S serum. 
Arrow indicates the point of application of antigen. 
Anode (+) is to the right in the first dimension and at the top 
In second dimension 
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0.0. at 490 nm 
600 1000 4000 16000 64000 296000 1000000 
Reciprocal antibody dilutions 
Fig. 15: Titration curves of unabsorbed and absorbed anti-E-S 
Serum against .S. cervi excretory-secretory products using 
ELISA. 
•Means of results in triplicate 
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in the filarial patient pooled sera (Fig. 16). On testing small number 
of individual human patient sera, the preabsorbed immune rabbit 
anti-i". cervi E-S serum could detect the circulating filarial antigen in 
all the 15 microfilarial positive patient sera but not in the 10 non-
endemic control human sera and also did not show any cross-reactivity 
with any non-filarial (ascaris, malaria, amoebae) patients' sera (Table 
3). 
III. FRACTIONATION OF S. CER VI E-S PRODUCTS 
The S. cervi E-S products were fractionated by ion-exchange 
chromatographic technique using DEAE-Sephacel column 
(Pharmacia). The elution was done by chloride gradient using different 
molarity of sodium chloride (NaCl) to elute the antigenic components 
of the S. cervi E-S products i.e. 100 mM, 250mM and 500mM NaCl. 
The protein started eluting with 250mM sodium chloride gradient and 
also continued with 500mM chloride gradient. Three ml of the 
firactions were collected. Each fi-action was measured in an 
spectrophotometer at 280 nm CD for the presence of proteins and this 
showed the presence of 3 distinct peaks showed in Fig. 17. These 
column fractions were further analysed in ELISA using rabbit anti-E-S 
serum and rabbit anti-BSA serum. All fractions showed high reactivity 
Table 3: Detection of circulating antigen in filarial patients' sera by 
CIEP using absorbed anti-ScE-S serum. 
Sera 
Filariasis 
(Mf+ve) 
Other 
Infections 
Ascaris 
Malaria 
Amoebae 
Non-Endemic 
Controls 
Number 
Tested 
15 
3 
10 
5 
10 
Positive by 
CIEP 
15 
0 
0 
0 
0 
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Fig. 16: Counter current immunoelectrophoretic pattern 
of patient pooled sera (a) and normal human serum (b) using 
absorbed (1) and unabsorbed (2) anti-ScE-S serum. 
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(O.D.) at 280 nm 
3 30 75 120 204 
100 mM 250 mM Elution Volume (mfl^ OO ""^ ^ 
Fig. 17: Fractionation profile of .S. cervi E-S products by 
DEAE-Sephacel column. 
OD at 490 nn 
Ant i -z-S serum - + - A n l i - B S A ser t 
lOOmM aeOmM Elution VoljjmeJmO. SPQmM 
Fig. 18: Reactivity of DEAE-Sephacel column fractions 
with anti-ScE-S serum and anti-BSA serum. 
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with anti-E-S serum whereas, only fractions 39-45 showed reactivity 
with the anti-BSA serum in ELISA (Fig. 18). 
According to their reactivity in ELISA the fractions were pooled 
in six different pools. These purified fraction pools (ScESPF) I-VI 
were further analysed in ELISA using rabbit anti-E-S serum and anti-
BSA serum. All the fraction pools showed high reactivity with anti-E-S 
serum while the anti-BSA serum showed positive results with column 
fraction III and IV, whereas no reactivity was found with the other 
column fractions as shown in Fig. 19. Further these column fraction 
pools (ScESPFI-VI) were tested in ELISA using Scl monoclonal 
antibody (previously prepared in our laboratory, which could 
successfully detect the filarial circulating antigen in patients' sera). 
Only column fraction pool I showed high reactivity at the monoclonal 
antibodies with all the three antibody dilutions tried, whereas, the 
ScESPF II-VI showed no reactivity with the monoclonal antibody, 
results shown in Fig. 20. Thus, indicating that the column fraction pool 
I contains the relevent antigen (equivalent to the filarial circulating 
antigen) and antibody against it could detect the circulating filarial 
antigen. Therefore, ScESPFI was used to immunize the BALB/c mice 
for the production of hybridoma clones. 
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IV. PRODUCTION OF MONOCLONAL ANTIBODIES 
AGAINST PURIFIED E-S PRODUCTS 
Five BALB/c mice were immunized subcutaneously with 20 )j,g 
of ScES purified antigen fraction pool I (ScESFPI) emulsified in 
Freund's complete adjuvant (FCA). The immune mice sera were 
collected and analysed in ELISA and CIEP against ScESPFI The 
immune mice sera of mice 1, 2 and 5 showed high antibody titre in the 
range of 1:3200-1:6400 while immune sera of mice 3 and 4 showed 
lower titre of 1:800-1:1600 (Table 4). Further, these immune mice sera 
were also analysed in CIEP to detect the circulating antigen in filarial 
patient sera. The immune sera of mice 1, 2 and 5 could successfully 
detect the circulating antigen in patients' sera while immune mice sera 
3 and 4 gave negative results also shown in Table 5. Out of the three 
mice, having sera positive for circulating antigen, two were selected for 
frision with Sp2/0 myeloma cell for hybridoma production. 
Two mice chosen for fusion were boosted with 10 fig of 
ScESFPI, by intervenous injection 4 days before fusion. The spleen 
cells from the immune animals were fused with Sp2/0 myeloma cells 
in polyethylene glycol and the cell suspension was plated in 24 well 
culture plates and grown in the presence of a selective hypoxanthine-
aminopterin-thymidine (HAT). After, HAT selection, the hybridoma 
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Table 4: Testing of the immune mice sera using purified 5. cervi 
E-S antigen in ELISA and counter current 
immunoelectrophoresis 
Immune mice 
sera 
IMSl 
IMS 2 
IMS 3 
IMS 4 
IMS 5 
ELISA 
1:6400 
1:3200 
1:1600 
1:800 
1:3200 
CIEP 
+ 
+ 
— 
— 
+ 
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were selected on the basis of their reactivity with both bovine (S. cervi) 
and human {B. malayi and W. bancrofti) filarial parasite antigens in 
ELISA. The hybrids showing high reactivity with both the antigens 
were selected and cloned twice by limiting dilution. The wells were 
examined microscopically and out of 264 wells plated 251 wells were 
found positive for the hybrid growth with a fusion efficiency of about 
95%. The culture supematants from these wells were tested in ELISA 
for the anti-filarial antibody against ScES and ScESPFI, B. malayi 
antigen and W. bancrofti microfilarial antigen and 69 hybrids (27%) 
were found to have anti-filarial antibody. Out of these 69 hybridomas, 
27 showed reactivity with the purified E-S antigen. The reactivity of 
the supematants were also tested in ELISA against {B. malayi and W. 
bancrofti) filarial parasite antigens. The supernatant from 36 
hybridomas showed reactivity with B. malayi adult antigen and the 
supematants from 21 hybridoma clones were positive against W. 
bancrofti microfilarial antigen. The reactivities of these hybridoma 
clones were also tested with non-filarial antigens in ELISA and 12 
hybridoma clones were found to be specific to filaria and did not show 
cross-reactivity with non-filarial antigens (data not shown). The 
monoclonal antibodies produced by four hybridoma clones (designated 
as FES 2, FES 7, FES 9 and FES 11), showing high and consistent 
reactivities with both bovine {S. cervi E-S and ScESPFI) and human 
{B. malayi and W. bancrofti) filarial antigens were selected for further 
studies. All the four monoclonal antibodies showed high reactivity with 
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the filarial circulating antigen present in filarial patient serum pool. The 
reactivities of these 12 hybridoma clones with the filarial antigens (both 
human, B. malayi and W. bancrofti, and bovine, S. cervi E-S and 
purified antigen) are shown in Table 5. All the hybridoma clones 
showed significantly high reactivity with the filarial antigens. 
i. Characterization of the monoclonal antibodies 
The isotyping analysis of the four monoclonal antibodies was 
performed using subclass specific reagents. The monoclonals FES 7 
and FES 9 were found to be IgG] antibody whereas, monoclonal 
antibody FES 2 belongs to IgG2b and FES 11 belongs to IgM isotype. 
Both positive and negative controls were used in each experiment. The 
Scl, a monoclonal antibody produced earlier in our laboratory 
(Kaushal et al, 1995) is an IgGi isotype was used as a positive control, 
while a malarial monoclonal antibody (DNKIO), kindly supplied by 
Dr. D. C. Kaushal, Division of Microbiology, Central Drug Research 
Institute, Lucknow (India) was used as negative control (Table 6). 
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Table 5: Reactivities of hybridoma clones with different filarial 
antigens in ELISA 
Hybridoma 
Clones 
FESl 
FES 2 
FES 3 
FES 4 
FES 5 
FES 6 
FES 7 
FES 8 
FES 9 
FES 10 
FES 11 
FES 12 
Scl 
DNKIO 
ScES 
0.489 
2.187 
2.059 
1.697 
2.168 
2.221 
1.997 
1.207 
2.207 
1.245 
2.045 
0.979 
2.462 
0.093 
ScESPFI 
0.832 
1.801 
1.661 
1.08 
1.595 
1.977 
1.709 
0.848 
1.997 
0.852 
1.882 
0.495 
1.287 
0.165 
BmA 
1.021 
1.772 
1.380 
1.301 
1.644 
1.795 
1.418 
1.011 
1.621 
0.988 
1.477 
0.671 
1.624 
0.082 
Wbmf 
0.781 
1.56 
1.492 
0.985 
1.541 
1.679 
1.237 
0.998 
1.889 
0.901 
1.289 
0.851 
1.654 
0.094 
Table 6: Isotype analysis and reactivities of anti-ScE-S monoclonal 
antibodies with filarial circulating antigen. 
Monoclonal 
Antibodies 
FES 2 
FES 7 
FES 9 
FES 11 
Scl 
DNKIO 
ELISA value (OD490) 
Isotype 
IgG2b 
IgG, 
IgG, 
IgM 
IgG, 
IgG, 
ScES 
2.658 
2.710 
3.150 
3.579 
2.878 
0.157 
Circulating 
Antigen 
0.635 
0.549 
0.675 
0.751 
0.638 
0.082 
*Reactivity with circulating antigen in pooled sere from W. bancrofti 
infected patients (positive for circulating antigen) was determined by 
sandwich ELISA 
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ii. Reactivity of monoclonal antibodies with different antigens 
The specificity of the four monoclonal antibodies was examined 
by testing their reactivity against a panel of non-filarial antigens such 
as ascaris, hookworm, malaria, amoebae and bacteria. The filarial 
antigens (5. malayi adult, W. bancrofti microfilariae, S. cervi adult, 
microfilarial, excretory-secretory products and purified antigens) were 
also used for comparison. The positive control used was S. cervi E-S 
antigens and the negative control was normal human serum (NHS) 
from the endemic area. All the four monoclonal antibodies (FES 2, 
FES 7, FES 9 and FES 11) exhibited high reactivity with all the filarial 
antigens {B. malayi, W. bancrofti, S. cervi adult, mf and purified 
antigen fraction). The FES 9 showed highest reactivity with all the 
filarial antigens (Table 7). With regards to the reactivities of four 
monoclonal antibodies with non-filarial antigens, none of the 
monoclonal showed any significant reactivity with any of the non-
filarial antigens (Table 8). These finding suggest the filaria specificity 
all the four monoclonal antibodies. 
iii. Analysis of the monoclonal antibodies in inhibition ELISA 
The inhibition ELISA was done using Scl-HRP conjugate. Out 
of the four monoclonal antibodies, FES 7, FES 9 and FES 11 strongly 
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Table 7: Reactivities of monoclonal antibodies with different 
filarial antigen 
Antigens 
Setaria cervi 
Excretory-
Secretory 
Purified 
Setaria cervi 
Adult somatic 
Setaria cervi 
Microfilaria! 
Somatic 
Brugia malayi 
Somatic adult 
Wuchereria 
bancrofti 
Microfilaria! 
Somatic 
ELISA value at (OD490) 
FES 2 
2.692 
2.667 
2.301 
2.438 
2.409 
2.312 
FES 7 
3.005 
2.945 
2.797 
2.810 
2.837 
2.611 
FES 9 
3.256 
3.106 
2.819 
2.915 
2.918 
2.815 
FES 11 
2.799 
2.794 
2.597 
2.398 
2.602 
2.408 
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Table 8: Reactivities of monoclonal antibodies using non-
filarial antigens 
Antigens 
Setaria cervi 
Excretory-
Secretory 
Ascaris 
Hookworm 
Malaria 
Amoebae 
Bacteria 
NHS 
ELISA value at (OD490) 
FES 2 FES 7 FES 9 
2.667 
0.231 
0.150 
0.180 
0.191 
0.122 
2.918 
0.215 
0.227 0.209 
0.134 
0.153 
0.167 
3.418 
0.212 
0.231 
0.185 0.149 
0.178 
0.171 
0.119 
FES 11 
2.804 
0.231 
0.229 
0.169 
0.198 
0.189 
0.137 
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inhibited the binding of Scl-HRP to the antigen, while monoclonal 
FES 2 did not exert any inhibitory effect on binding. These results 
suggest that the three MoAbs (FES 7, FES 9 and FES 11) are directed 
against the same epitope that of Scl monoclonal antibody and the 
target epitope of FES 2 monoclonal appeared to be different. The 
results are given in Table 9, 
iv. Titration of monoclonal antibody-HRP conjugate in ELISA 
In order to test these monoclonal antibodies in sandwich ELISA 
for detection of circulating antigen, the monoclonal antibodies were 
purified and conjugated to horse radish peroxidase. The monoclonal 
antibodies FES 2, FES 7 and FES 9 were affinity purified using 
protein-A Sepharose column while the FES 11 monoclonal antibody 
was purified on Sephacryl S-200 column. The purified monoclonal 
antibodies were conjugated with horse radish peroxidase and HRP 
conjugates were tested at different dilutions against ScESPFI in 
ELISA. Two fold dilutions starting from 1:250 to 1:8000 were used 
and the titration curves are shown in Fig. 21. The two monoclonal 
antibody conjugates (FES 7-HRP and FES 9-HRP) showed optimum 
ELISA (OD) upto 1:1000 dilution while FES 2 gave optimum results 
upto 1:500 dilution. The optimum dilution of FES 9-HRP conjugates 
102? 
Table 9: Epitope analysis of monoclonal antibodies using 
inhibition ELISA 
Monoclonal 
Antibodies 
Inhibition ELISA (OD490) 
Scl-HRP % Inhibition 
FES 2 
FES 7 
FES 9 
FES 11 
Scl 
DNKIO 
1.961 
0.336 
0.188 
0.026 
0.031 
1.958 
7.41 
84.24 
91.18 
98.78 
98.55 
8.10 
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Fig. 21: Titration of monoclonal antibodies-HRP conjugate 
at different dilutions in ELISA 
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was found to be 1:2000. These HRP conjugates were used in sandwich 
ELISA at respective dilutions. 
V. DEVELOPMENT OF IMMUNODIAGNOSTIC TEST FOR 
FILARIASIS USING ANTI-E-S ANTIBODIES 
In order to evaluate the diagnostic potential of anti-ScE-S 
monoclonal antibodies for the detection of filarial circulating antigen in 
patients' sera, all the four monoclonal antibodies (FES 2, FES 7, FES 9 
and FES 11) were used in sandwich ELISA in combination with Scl 
monoclonal antibody (an IgGj isotype directed against a repetitive 
protien epitope, detecting the filarial circulating antigen, previously 
developed in our laboratory). The Scl monoclonal antibody was used 
for the capturing of antigen. The sandwich ELISA was standardised In 
terms of optimum concentration of antibodies to capture and reveal the 
antigen. Out of different concentrations tried, 2 |ig/well concentration 
of Scl monoclonal for capturing of antigen and 1:1000 dilution in case 
of peroxidase conjugated FES 7, FES 9, FES 11 and !:500 dilution of 
peroxidase' conjugate FES 2 for the revealing step showed better 
results. In case of anti-ScE-S antibodies for the revealing step 1:2000 
dilution was found to be optimum. Out of the four monoclonals the 
combination of Scl-FES 9 showed higher sensitivity in detecting the 
antigen as this could detect 2.5 ng of antigen, while other monoclonal 
\oc 
combination showed slightly lower sensitivity i.e detecting 5-10 ng of 
antigen (Table 10). These monoclonal antibodies were further tried as 
capturing antibody in combination with the anti-ScE-S polyclonal (for 
revealing the antigen). The combination of FES 9-polyclonal resulted 
in increasing the detection limit as it could detect 0.62 ng of antigen 
(Table 11). 
The sandwich ELISA employing the combination of FES 9 
monoclonal-anti-ScE-S polyclonal was used for the detection of 
antigen in filarial patient sera. The sera collected from the 
microfilareamic positive filarial patient along with the endemic and 
non-endemic controls and also from patient having non-filarial 
infections were used in sandwich ELISA.The FES 9 -polyclonal based 
sandwich ELISA could detect antigen in all the microfilariae positive 
filarial patient sera as well as in one of non-endemic control serum 
which was also found positive for microfilariae. None of the other 
infection sera nor the non-endemic control sera were found positive by 
the sandwich ELISA (Table 12). 
Therefore in the present study we have been able to identify and 
characterize the excretory-secretory products from adults of S. cervi, a 
bovine filarial parasite. The hyperimmune rabbit serum raised against 
the 5. cervi E-S products showed high antibody titre and could identify 
10-12 antigenic components, out of which 2-3 antigens were of host 
origin and one being identified as serum albumin. These host serum 
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Table 10; Titration of monoclonal antibodies-HRP conjugate at 
different concentration of purified antigen using sandwich ELISA. 
Antigen 
(ng) 
100 
50 
25 
10 
5 
2.5 
1.25 
0.62 
0 
ELISA value at (OD490) 
Scl-Scl 
2.198 
1.972 
1.342 
0.984 
0.597 
0.389 
0.238 
0.201 
0.128 
Scl-FES2 Scl-FES7 Scl-FES9 Scl-FES 11 
1.819 
1.562 
1.205 
0.744 
0.492 
0.287 
0.229 
0.189 
0.112 
2.117 
1.834 
1.312 
0.905 
0.531 
0.329 
0.245 
0.205 
0.126 
2.679 
2.434 
1.925 
1.179 
0.873 
0.596 
0.34^ 
0.298 
0.131 
2.005 
1.797 
1.289 
0.875 
0.516 
0.311 
0.233 
0.198 
0.119 
-Scl monoclonal was used at 2 |j,g/well concentration for the 
capturing of antigen (Kaushal et ai, 1994) 
-The anti-E-S monoclonal FES 2, FES 7, FES 9 and FES 11 were 
conjugated to horse radish peroxidase by the method of Nakane and 
Kawoi (1974) and used as revealing antibodies FES 2-HRP was used 
at 1:500 dilution and the other monoclonals were used at 1:1000 
dilution 
Table 11: Sandwich ELISA using combination of monoclonal and 
polyclonal antibodies using different concentration of purified antigen. 
Antigen (ng) 
100 
50 
25 
10 
5 
2.5 
1.2 
0.62 
0.31 
0 
FES9-FES9 
2.598 
2.598 
1.901 
1.168 
0.815 
0.508 
0.327 
0.238 
0.145 
0.121 
ELISA(OD490nJ 
FES9-Polyclonal 
3.212 
3.029 
2.808 
1.982 
1.301 
0.956 
0.695 
0.541 
0.262 
0.128 
Scl-polyclonal 
3.091 
2.904 
2.415 
1.818 
1.101 
0.898 
0.545 
0.321 
0.232 
0.112 
-The FES 9 and Scl monoclonals were used at 2 |a,g/well to capture antibody 
-The anti-E-S polyclonal was used at 1:2000 dilution. 
loq 
Table 12: Sandwich ELISA for detection of circulating antigen in 
filarial patient sera using combination of monoclonal and polyclonal 
antibodies. 
Sera 
FilariaKMf +ve) 
Endemic 
Control 
Other 
Infection 
Ascaris 
Amoebae 
Malaria 
Non-Endemic 
control 
Number tested 
69 
18 
5 
5 
10 
35 
Positive for 
circulating antigen 
69 
1 (Mf +ve)* 
0 
0 
0 
0 
*One of the endemic control sera found positive by sandwich 
was also positive for microfilariae. 
no 
albumin could be removed by absorption with anti-BSA antibodies. 
The potential of anti-E-S serum was evaluated for the detection of 
filarial circulating antigen and it successfully detected the circulating 
antigen if filarial patient. The fi-actionation of the S. cervi E-S products 
on DEAE-sephacel results in isolating a purified E-S fraction showing 
reactivity with monoclonal (detecting circulating antigen). The 
monoclonal antibodies produced against ScES purified antigen fraction 
I and out of 4 monoclonals showing high reactivity, one showed 
potential for developing antigen detection test for human filariasis. 
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DISCUSSIONS 
Filariasis is a serious disabilitating parasitic disease. The filarial 
parasites W. bancrofti, B. malayi and B. trimori are the major cause of 
human lymphatic filariasis in the tropical and sub-tropical regions of 
the world with an estimated 120 million people infected and an 
additional 900 million people at the risk of infection (Ottesen and 
Ramachandran, 1995). One of the routine ways of diagnosing active 
filarial infection is by detecting the presence of microfilaria in the 
blood smears (Eberhard and Lammie, 1991). This method is less 
sensitive because of the nocturnal periodicity and of missing 
microfilaria in the blood smear if they are present in extremely low 
numbers and thereby introducing an error in diagnosing the active 
infection. The circulating filarial antigen was first demonstrated in 
bancroftian filariasis by Frank in 1946, with the technique of passive 
cutaneous anaphylaxis. The circulating antigen in the body fluids 
(serum and urine) of microfilareamic and clinical filarial patients has 
been suggested to be a better approach for the immunodiagnosis of 
filariasis (Ottesen, 1980; 1984; Harinath, 1986) as it is much more 
effective for assessing the status of an early and active infection. 
The E-S products, released by the living parasites in the host and 
these are the antigens which may probably be present in the circulation. 
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The demonstration of the E-S antigens in the circulation of the 
infected host could provide a better indicator for active filarial 
infection (Kaliraj et ah, 1979a). Inspite of the less complex nature of 
the filarial E-S antigens, (Kaushal et al, 1982; 1984; 1989; Prasad et 
ai, 1983; Kharat et al., 1983; Malhotra et al., 1987). not much efforts 
have been made to critically characterize and identify the 
diagnostically important antigen present in the E-S products. This may 
probably be due to the limitations in obtaining sufficient amount of 
E-S products from human filarial parasites (Kaushal et al., 1982; 
1984; Kharat et al., 1983). In the present study, an effort was made to 
analyze qualitatively and quantitatively the E-S products of S. cervi 
adults and to fractionate the E-S products in order to identify and 
isolate the antigen(s) equivalent to the filarial circulating antigen. The 
antibodies produced against these antigens have been evaluated for 
their potential to detect the circulating antigen in filarial patient sera. 
Setaria cervi, a bovine filarial parasite, was used as an alternate source 
for human filarial parasite antigens because the earlier studies from our 
laboratory on the characterization of S. cervi antigens, has identified 
some common antigenic epitopes between the bovine and human 
filarial parasites (Kaushal et al., 1987) and the monoclonal antibodies 
against the common epitope of high molecular weight antigen 
showed reactivity with the filarial circulating antigen (Kaushal et al., 
1994b). 
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In the present study E-S products from S. cervi adult worms 
were prepared by maintenance of parasites in vitro in serum free 
culture medium, conditions for preparing the E-S products were 
optimized and 32 hrs incubation period and DMEM appeared to be the 
best for getting the better recovery of E-S products at 37°C. The 
amount of protein released during the preparation of S. cervi E-S 
products by the adult filarial parasites was far greater (2-15 mg of E-
S products per 100 S. cervi adult parasites) than that reported for the 
other filarial parasites. Kaushal et al. (1982) obtained as low as 18 
fxgs of protein after incubating 100 B. malayi adult in synthetic 
medium for a duration of 48 hr. Rotmans et a/. (1981) have reported 
the release of 100 |ig protein/100 Schistosoma mansoni worms by 
maintaining them in medium 199 for 24 hrs. The release of large 
amounts of E-S products by the S. cervi adult parasites, fascilitated 
their characterization using conventional immunochemical methods 
and use for developing immunodiagnostic reagents. 
The protein pattern of S cervi E-S products was analyzed on SDS-
polyacrylamide gel elecfrophoresis which revealed the presence of 
14-15 protein bands in the molecular weight range of 10-200 kD, 
whereas, the crude somatic antigenic preparation contained 35-40 
protein bands thus, indicating the less complex nature of the S. cervi 
E-S products as compared to the somatic antigen whole worm 
extract of 5. cem. The B. wa/ayz products were also found to be less 
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complex in nature having eleven protein bands in the molecular weight 
range of 10 kD to 70 kD (Kaushal et al, 1982). Few protein bands 
having low molecular weight were also reported for the E-S product of 
L. carina (Rajasekhariah et al, 1986b) and O. volvulus mf (Ngu et al, 
1981). Antigens of the molecular weight of 17 and 21 kD were 
synthesized and release by the mf and L3 stages of W. bancrofti and the 
17 kD antigen was located on the surface of these stages (Maizels et 
al, 1986). 
In order to produce polyclonal antibodies against S. cervi E-S 
products, rabbits were immunized and the immune sera obtained 
from these rabbits were tested in ELISA using ScE-S products. To 
optimize the assay conditions, optimum antigen concentration and the 
optimum dilution of the anti-ScE-S antibodies were determined. Out of 
different concentrations of antigen (ScE-S) tried, optimum results were 
obtained at 0.25 fig/well. The decrease in antigen concentrations 
resulted in decrease ELISA values. The B. pahangi E-S products 
showed the optimum antigen concentration as low as 10 ng/ml when 
tested in ELISA (Maizels et al, 1985). Using this optimum antigen 
concentration the immune rabbit sera from the three rabbits gave high 
antibody titres in the range of 1:100 000 to 1:250 000. The increase in 
tifre value with increasing number of immunization was observed in 
all the three rabbits, which became constant after the 8**' injection. 
The results indicate the highly immunogenic nature of S. cervi E-S 
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products. The immunogenic nature of E-S products from filarial and 
other nematode parasites have been shown by a number of studies. In 
case of B. malayi E-S antigens 5 ng antigen/well showed optimum 
results (Kaushal etal, 1982; Weil, 1988). 
The antigenic pattern of iS. cervi E-S products were analyzed by 
employing the technique of crossed Immunoelectrophoresis (CIE) 
using the rabbit anti-5'. cervi E-S antibodies. The CIE is sophisticated 
reasonably sensitive and semi-quantitative technique which gave 
better resolution of the antigenic components of the S. cervi E-S 
products. The immune rabbit sera obtained from the three rabbits 
showed comparable antigenic pattern of S. cervi E-S antigen in CIE 
except for the slight differences in the intensity and the heights of 
certain peaks were observed. The number of peaks remained the same 
in all the different concentrations of the serum tried,, but the optimum 
resolution of the precipitin peaks was observed using 10% serum 
concentration in case of immune rabbit serum 1 (IRS 1), which showed 
comparatively lower antibody titre, whereas, in case of immune rabbit 
serum 2 (IRS 2) and 3 (IRS 3) lower serum concentration (5% v/v) was 
required to get a better resolution. A careful examination of CIE 
pattern revealed the presence of 10-14 antigenic peaks in S. cervi E-
S product. Earlier the technique of CIE has been employed by various 
workers to analyze the antigenic components of filarial and other 
parasites (Kaushal et al., 1982; Malhotra et al, 1987; Mohan et al. 
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1988; Haider e? a/., 1990, Sugunan etal, 1990). Kaushale?al.(1982) 
could resolve the B. malayi E-S antigens in 10-11 precipitin peaks 
using CIE. However, the S. digitata E-S products showed the 
presence of only 3-4 antigenic peaks by the same technique (Sugunan 
and Raj, 1990). 
The parasitic worms are known to adsorb host proteins on their 
surfaces to get established in the host by protecting themselves from 
the immunologically hostile environment of the host, (Smither et 
ah, 1969). The S. cervi adult worm resides on the peritoneal folds of 
the buffaloes and the adsorption of the host protein can subsequently be 
released into the in vitro maintenance medium during the preparation 
of E-S products. Host serum proteins have been shown to be present on 
the surfaces and E-S products of other certain filarial and other helmith 
parasites (Mania and Kar, 1994). The results of the present study 
indicated the presence of 3-4 host proteins contamination in S. cervi 
E-S products. One of the major components was found to be serum 
albumin which was confirmed by absorbing the ScE-S with rabbit anti-
BSA antibodies and the anti-^ ". cervi E-S serum with BSA-sepharose 
sorbent. Kaushal et al. (1982) have identified host serum protein 
contaminants on the surface adult and microfilarial stages as well as in 
the E-S products of human filarial parasites B. malayi. Albumin has 
been shown to mark the surfaces of W. bancrofti microfilaria! antigen 
(Kar et al, 1993; Mania and Kar 1994). 
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Various immunodiagnostic techniques based on the detection 
of circulating antigen has been employed by a number of workers 
(Au ef a/., 1981; Des Moutis et al, 1983; Kaliraj e/a/., 1981a; 
Ouassiefa/., 1981; Phillip et al, 1982; Dissanayake et al, 1984; 
Forsyth et al, 1985; Hamilton et al, 1984; Reddy et al, 1984b; c) 
and the counter current Immunoelectrophoresis (CIEP) was one of 
them. The counter current Immunoelectrophoresis (CIEP) has earlier 
been used for the detection of filarial circulating antigen by a 
number of workers (Kaliraj et al,\ 979; 1981 a; Dasgupta et al, 1984; 
Weil et al, 1984a; 1986a).This method appears to be reasonably 
sensitive and convenient to perform as compared to night blood 
examination for the presence of microfilariae, but the problem of 
specificity was encountered as antibodies used in these studies were 
against the crude somatic extracts of filarial parasite (Weil et al, 
1984a; 1986; Hamilton et al, 1984). In the present study, the 
polyclonal antibodies raised in rabbits against S. cervi E-S antigens 
were used for the detection of circulating antigen in filarial patient 
using small number of serum samples. The hyperimmune serum from 
all the three rabbits were found to have antibodies against filarial 
circulating antigen. Initially, these immune rabbit sera showed non-
specific reaction with normal human serum in CIEP. However, this 
non-specificity was removed by preabsorbing the immune rabbit sera 
with albumin-sepharose. The preabsorbed anti-E-S serum could detect 
the circulating antigen in all the microfilariae positive patient sera but 
l]S 
not in the non-endemic control sera from the healthy individuals used 
in the study. 
Detection of circulating antigen, however, can be complicated 
by the binding of antigen into immune complexes (Hamilton et ai, 
1984). Such complexes are common in sera from patients with 
filariasis (Au er a/., 1981; Steward et ai, 1982; Chandershekhar e/ 
ai, 1990; Das ef al., 1988a; Dissanayake et al., 1982; Lutsch et al, 
1988; Thambiah et al, 1992). Variability in the amount of serum 
antigen in free and bound state may make difficult the detection of 
circulating antigen. Therefore, in the present study the filarial patient 
sera were pretreated with EDTA and heated to release the antigen 
from the immune complexes, thus, in turn increasing the sensitivity of 
the assay. Earlier studies from our laboratory on identification and 
characetrization of antigens of human {B. malayi) and bovine {S. cervi) 
filarial parsites revealed common antigens between these two parasites. 
In the present study, the fractionation and immunochemical 
characterization of S. cervi E-S products was done in order to identify 
and isolate the antigen(s) equivalent to filarial circulating antigen and 
having potential for developing immunodiagnostic reagents for antigen 
detection. 
The S. cervi E-S products were fractionated using DEAE-
Sephacel column which resulted in the resolution of three distinct 
protein peaks. All these fractions showed high immuno-reactivity with 
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rabbit anti-E-S serum while only few fractions were reactive with anti-
BSA serum in ELISA. Based on their reactivity in ELISA the fractions 
were pooled in six different antigen pools fractions. Among the six 
ScE-S purified fractions only fraction I (ScESPFI) showed 
significantly high reactivity with monoclonal antibody Scl (prepared 
previously in our laboratory detecting the circulating antigen in human 
patient sera)Antigens from human filarial parasites have been antigens 
isolated from blood (Reddy et al, 1986), hydrocoele fluid (Malhotra et 
al, 1985; Ramaprasad and Harinath, 1987) of infected patients and 
have been used as diagnostic reagents. 
In the present study, the ScESPFI has been used to produce 
monoclonal antibodies to evaluate its diagnostic potential. The 
selection of hybridoma clones was done on the basis of their reactivity 
with both bovine and human flleirial parasite in order to identify the 
clones against common antigenic epitopes. In all the fusions done in 
the present study high fusion efficiency (96%) was obtained. The 
present studies resulted in the identification of 12 monoclonal 
antibodies showing high and consistent reactivity with both bovine and 
human filarial parasites thereby suggesting that these monoclonal 
antibodies are against the shared antigens of these parasites. The 
monoclonal antibodies against the common antigenic epitopes of 
human and animal parasites (Dirofilariae immitis and Onchocerca 
gibsoni) have earlier been produced (Dissanayake et al., 1984; Weil 
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and Liftis, 1987), Out of the 12 hybridoma clones, four monoclonal 
antibodies (designated as FES 2, FES 7, FES 9and FES 11) were found 
to show high affinity for the filarial circulating antigen present in 
filarial patient sera. Scl, monoclonal antibody an IgGi isotype directed 
against a non-phosphorylcholine repetitive epitope , (prepared 
previously in our laboratory) and detecting the circulating filarial 
antigen in human patient sera was used as positive control in all the 
experiments.The target epitopes of these monoclonal antibodies 
appears to be present not only in S. cervi antigenic preparations (ScA, 
Scmf, ScES and ScESPFI) but also in the somatic extracts of the other 
filarial parasites, as shown by high reactivity of these monoclonal 
antibodies with B. malayi and W. bancrofti antigen. However, all the 
four monoclonal antibodies did not cross-react with the antigens 
obtained from the non-filarial parasites. This lack of cross-reactivity of 
the monoclonals with non-filarial antigens and the high reactivity with 
different filarial parasite antigens suggest filaria-specificity of these 
monoclonal antibodies. The isotyping analysis of four monoclonals 
revealed FES 2as IgGzb, FES 7 and FES 9 as IgG, and FES 1 las IgM 
isotype. 
These monoclonals were further characterized for their epitope 
specificity.The epitope specificty of all the four monoclonals were 
assessed by inhibition ELISA using Scl-HRP conjugate. The results of 
the inhibition ELISA indicated that the three monoclonals (FES 7, FES 
12( 
9 and FES 11) are directed against the target epitope of Scl 
monoclonal antibody as revealed by strong inhibition of binding of 
Scl-HRP By all the three monoclonal antibodies. However, the FES 2 
appeared to be directed against a different epitope as it did not have 
effect on binding of Scl-HRP to filarial antigen. The potential of these 
4 monoclonal antibodies (FES 2, FES 7, FES 9 and FES 11) was 
evaluated for the detection of circulating antigen in filarial patient sera 
by sandwich ELISA. 
A number of antigen detection assays have been developed by 
several investigators using monoclonal anti bodies against antigens 
fi-om animal filarial parasites (Des Moutis et al., 1983; Dissanayake et 
ah, 1984; Forsyth et ah, 1985). The Gib-13 was the first monoclonal 
antibody (produced against O. gibsoni egg antigen) that was used to 
develop an immunoradiometric assay (IRMA) for the detection of 
antigen in bancroftian filariasis (Forsyth et al, 1985). Unfortunately 
none of these assays could be integrated in filaria control programmes 
as these test has either been insufficiently sensitive or technically 
demanding for use outside the specialized laboratories. Few other 
monoclonal antibodies, which were produced against the common 
antigenic epitopes of human and animal filarial parasites, include the 
monoclonals produced against D. immitis (Weil et al, 1987); 
O. gibsoni adult antigen (More and Copeman, 1990). These 
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monoclonal antibodies have been used to develop antigen detection test 
for bancroftian filariasis and these are under commercialisation. 
In our laboratory we have produced a monoclonal antibody 
(Scl) against an antigenic epitope common between the bovine and 
human filarial parasite. The Scl monoclonal is an IgGi isotype, 
directed against a non-phosphorylcholine, heat stable, repetitive 
epitope (Kaushal et ai, 1994). The Scl based sandwich ELISA, though 
highly specific for diagnosing active filarial infection, the sensitivity of 
the test was not upto the mark. In the present study, we have evaluated 
the diagnostic potential of anti-E-S monoclonal and polyclonal 
antibodies in combination with Scl monoclonal antibody. All the four 
anti-ScE-S monoclonal antibodies (FES 2, FES 7, FES 9 and FES 11) 
were conjugated to HRP and evaluated in sandwich ELISA for antigen 
detection. A sandwich ELISA was standardised in terms of optimum 
concentration of antibody (developed earlier in our laboratory, 
detecting circulating antigen) was used as capturing antibody and used 
in combination with the peroxidase conjugated anti-E-S monoclonal 
antibodies (for revealing step) in sandwich ELISA. Out of different 
combinations (Scl-FES2, Scl-FES 7, Scl-FES 9 and Scl-FES 11) 
tried, the combination of Scl-FES 9 showed better sensitivity for 
antigen detection as compared to other monoclonal antibodies. When 
these monoclonal antibodies (as capturing antibodies) were used in 
combination with the peroxidase conjugated rabbit anti-ScE-S antibody 
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(as revealing antibody), the FES 9 monoclonal-polyclonal combination 
showed better sensitivity for antigen detection. The better results 
obtained with FES 9 monoclonals may be attributed to the high affinity 
of this monoclonal antibody for the antigen. Differences in the 
affinities of different monoclonal antibodies have been observed 
(Kaushal et al., 1994; 1995). The FES 9-polyclonal sandwich ELISA 
was evaluated for its immunodiagnostic potential using patients' sera 
from filarial (microfilariae positive), non-filarial infections (ascaris, 
amoebae, malaria) infections as well as endemic and non-endemic 
control sera. The results of the present study revealed that the FES 9-
polyclonal system is highly sensitive as it could detect antigen in all the 
microfilarial positive patients' sera. One of the endemic control sera 
positive by the sandwich ELISA was found to be positive for 
microfilariae. The specificity of the system (FES 9-polyclonal ELISA) 
was evident by the negative results obtained in case of other infection 
sera (ascaris, amoebae and malaria) and the non-endemic control sera. 
A sandwich ELISA, employing monoclonal antibody (AD 12) against 
dog filarial parasite antigen showed a sensitivity of 95% in filaria 
diagnosis (Weil and Liftis, 1987; Weil et a/., 1989). However, the 
problem with this monoclonal antibody is that it is directed against a 
carbohydrate epitope and thus may not be very suitable for specific 
diagnosis of human filariasis. 
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In conclusion, the excretory-secretory products from S. cervi 
adults Ccin be obtained by short term in vitro maintenance of filarial 
adult worms in protein free defined medium.The polyclonal antibodies 
produced against .S". cervi E-S products showed high antibody titres and 
revealed 10-14 antigenic proteins in the ScE-S products. The S. cervi 
E-S products were found to contain host serum albumin which can be 
removed by absorption with anti-BSA antibodies. The fractionation of 
iS". cervi E-S products led to the isolation of an antigen fraction which 
may contain antigens equivalent to filarial circulating antigen as the 
antibodies against this fraction showed reactivity with filarial 
circulating antigen. We have been able to produce monoclonal 
antibodies against this purified S. cervi E-S purified fraction. Out of 4 
monoclonal antibodies specific to filaria, one showed better sensitivity, 
when used in combination with anti-E-S polyclonal, for detecting 
circulating antigen in filarial patients' sera. A logical extension of these 
studies to use this anti-ScE-S monoclonal-polyclonal combinations for 
developing specific 
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CHAPTER IV 
SUMMARY 
AND 
CONCLUSIONS 
Filariasis is a major health problem in tropical and subtropical 
countries. It is caused by the parasites belonging to class filaroidea, 
which have complex life cycle that alternates between an arthropod and 
vertebrate host. Though, the disease is not fatal, but. these parasites 
cause lymphatic damage that leads to elephantiasis and hydrocoele 
which is responsible for considerable disability and social stigma. 
Important pathogenic species infecting humans are Wuchereria 
bancrofti, Brugia malayi and B. trimori. In India over 90% of the 
disease is caused by Wuchereria bancrofti. 
The unequivocal diagnosis of filarial infection still largely 
depends on the detection of the microfilariae in the blood. Nocturnal 
periodicity of microfilariae imposes a practical limitation on the 
effective use of microfilaria detection of lymphatic filariasis because of 
the need for night blood sampling. The parasitological method is 
inconvenient for both the patient as well as the investigator and fails to 
detect the amicrofilaraemic stage of the disease or when mf are 
present in very small numbers. This has put forward an emphasis for 
improved immunodiagnostic methods for species and accurte diagnosis 
of active filarial infection. 
Earlier studies on immunodiagnosis of filariasis was focussed 
mainly on the demonstration of antibodies to filarial antigens. The 
major disadvantage of the immunodiagnostic test based on antibody 
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detection is their inability to distinguish between the past exposure and 
current infections as well as their cross-reactivity with other helminth 
parasites. The detection of filarial circulating antigen in blood and 
other body fluids of infected individuals has been shown to be a better 
approach for diagnosing active filarial infections. Though a number of 
antigen detection assays have been developed but the problem of 
sensitivity and specificity of these assays still remains. There is still a 
need to identify specific filarial antigen for developing better 
immunodiagnostic reagents. 
Due to the non-availability nof human filarial parasites in 
sufficient quantities, heterologous antigens from animal filarial parasite 
including S. cervi (bovine filarial parasite) have been used for 
developing immunodiagnostics. However, the use of antibodies 
prepared against crude antigenic preparation results in false positive 
reactions.This may be due to complex nature of these antigens and 
their cross-reactivity with other helminths parasites. Polyclonal 
antibodies against purified or simple antigenic preparations or 
monoclonal antibodies against filaria-specific epitopes are required for 
developing specific immunodiagnostic methods. The excretory-
seretory antigens released by the living parasites in the host are known 
to be less complex in nature and may contain antigen(s) equivalent to 
filarial circulating antigen. The present study was undertaken on the 
characterization of excretory-secretory products of S. cervi (bovine 
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filarial parasite) to identify the antien equivalent to filarial circulating 
antigen, production of antibodies against these antigens. 
The studies were initiated with the preparation of S. cervi E-S 
products, by maintaining the adult parasites asceptically in protein free 
medium (DMEM) for 32 hrs at 37°C. Substantial amount (12-15 mg 
protein/100 worms) of E-S products were obtained fi-om S. cervi adult 
by maintainin in DMEM and the worms remained motile for the 
maximum period of time without change of medium. The release of 
large amount of protein facilitated the fractionation and 
characterization of .S. cervi E-S products. The SDS-polyacrylamide gel 
electrophoretic analysis of S. cervi E-S products showed the presence 
of 14-15 protein bands in molecular weight range of 10-200 kD. 
Theseresults revealed less complex nature of ScE-S products as 
compared to S. cervi somatic antigenic preparation which showed 30-
35 protein bands using hyperimmune rabbit serum. The ScE-S products 
were used to immunized the rabbits for raising hyperimmune 
polyvalent serum. Three rabbits (Rl, R2 & R3) were immunized over a 
period of 5-6 months. The immune rabbit sera collected after each 
immunization starting from the 3"* injection and were tested for the 
parasite specific antibodies by employing enzyme linked-
immunosorbent assay (ELISA). An increase in the antibody titre, with 
increasing number of immunization, was observed and the titre value 
became constant after VIII* injection in all the three rabbits (IRS 1, 
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IRS 2 and IRS 3). The immune serum pool from IRS 1 showed the 
reciprocal antibody titre of 128 000, while the reciprocal antibody titre 
of 256 000 were observed for IRS 2and IRS 3 pools. The antigenic 
components of 5. cervi E-S antigens were analysed by employing the 
techniques of CIE using rabbit anti-iS. cervi E-S serum. The best 
resolution in CIE was obtained by using 5-10% concentration of anti-5. 
cervi E-S serum and it revealed the presence of 10-12 precipitin peaks 
in E-S products. 
Parasite worms are known to adsorb host serum proteins (mainly 
albumin) on their surfaces in order to evade the immunologically 
hostile environment of the host. The S. cervi adult worms resides on the 
peritoneal folds of buffaloes and absorption of normal host proteins 
and their subsequent release during in vitro maintenance is likely to 
occur. In the present study, the S. cervi E-S products were also 
analysed for the presence of host serum protein contaminents by 
using rabbit anti-normal buffalo serum and it showed the presence of 
3-4 host proteins. Further, efforts were made to characterize these host 
protein contaminants by using the techniques such as crossed line 
Immunoelectrophoresis (CLIE) and tandem crossed 
Immunoelectrophoresis (TCIE). The CLIE was done by adopting two 
ways, firstly the BSA was introduced in the intermediate gel and 
secondly by introducing the rabbit anti-BSA serum in the intermediate 
gel, and the rabbit anti-E-S serum was used in both the cases. In the 
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former case, when BSA was used in the intermediate gel, two 
precipitin peaks of the E-S products showed Hnes at their bases. The 
reduction in the heights of the same precipitin peaks was observed in 
the latter case. In case of TCIE, BSA was run along with the E-S 
products in the first dimension, using the rabbit anti-E-S serum, and it 
showed considerable increase in the heights of the same two 
corresponding precipitin peaks as observed in case of CLIE. The above 
results with CLEE and TCIE indicates that the major components of 
host serum proteins is albumin. 
The rabbit anti-E-S serum was evaluated for its potential to 
detect circulating antigen in filarial patient serum. Initially, the rabbit 
anti-ScE-S serum showed non-specific reaction with the normal 
human serum. This may be due to the presence of host serum albumin 
in the S. cervi E-S products. Therefore, efforts were made to absorb 
the host serum proteins from the S. cervi E-S products using anti-
BSA sepharose beads. The preabsorbed .S. cervi E-S products were 
analysed using SDS-PAGE, CIE and ELISA. The SDS-PAGE analysis 
of the preabsorbed E-S products showed the removal of major 66 kD 
protein band, which was present in the unabsorbed S. cervi E-S 
products. The antigenic analysis by CIE, using rabbit anti-E-S serum., 
revealed the presence of 10 precipitin peaks in the preabsorbed E-
S products. On testing the preabsorbed S. cervi E-S products in ELISA 
against rabbit anti-ScE-S serum, the antibody titre was of 1:120 000. 
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Similarly, the absorption of rabbit anti-S. cervi E-S serum on BSA-
sepharose beads, resulted in the removal of the antibodies against the 
host protein components. The preabsorbed rabbit anti-ScE-S serum, 
showed the removal of the antibodies against the two major host 
protein contaminants of E-S products. This preabsorbed rabbit anti-
ScE-S serum, when tested in ELISA against S. cervi E-S products, 
gave an antibody titre of 1:120 000 as compared to the reciprocal 
antibody titre of 250 000 obtained for the unabsorbed anti-E-S serum. 
The preabsorbed anti-E-S serum was evaluated for the detection of 
circulating filarial antigen in patient sera by counter current 
Immunoelectrophoresis. This absorbed rabbit anti-E-S serum showed 
no cross-reactivity with the normal human serum, and could 
successfully detect the circulating antigen in the filarial patient sera. 
The fractionation of S. cervi E-S products on DEAE-Sephacel 
column yeilded 3 major protein peaks. Six antigen fraction pools were 
made according to their reactivity with rabbit anti-E-S serum and rabbit 
anti-BSA serum. The reactivities of the antigen fraction pools were 
tested against the monoclonal antibody (detecting the filarial 
circulating antigen) in ELISA. The ScESPFI showed high reactivity 
with the monoclonal antibody, whereas, all other antigen fraction pools 
did not show any significant reactivity. Therefore, the ScESPFI which 
may be having the antigen equivalent to the filarial circulating antigen, 
was used to immunize the mice for hybridoma production. 
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The production of monoclonal antibodies against S. cervi E-S 
products was done by the fusion of spleen cells from mice (immunized 
against ScESPFI) with myeloma cells. A fusion efficiency of 96% was 
obtained. The 69 hybridoma clones showed reactivity reactivity with S. 
cervi antigens, 27 with ScESFPI, 36 with B. malayi adult antigen and 
21 with W. bancrofti microfilarial antigens. A total of 12 monoclonal 
antibodies having consistent reactivity with both bovine and human 
parasites were selected and out of these four monoclonal antibodies 
(FES 2, FES 7, FES 9and FES 11) were found to have high affinity for 
the filarial circulating antigen. All the 4 monoclonals showed high 
reactivity with human {B. malayi and W. bancrofti) and bovine filarial 
{S. cervi E-S, ScESFPI, ScA and ScMf) antigen but the highest 
reactivity in all the cases was observed with FES 9 monoclonal 
antibody. None of these monoclonal antibodies showed reactivity with 
any significant the non-filarial antigens (ascaris, hookworm, malaria, 
amoebae, bacteria) indicate the specificity of the monoclonal 
antibodies to filarial antigen.Isotyping analysis revealed that one (FES 
2) out of four monoclonals, was found IgGib one (FESl 1) was IgM and 
two (FES 7and FES 9) were IgGi isotype.The target epitope of the tree 
monoclonal antibodies (FES 7, FES 9, FES 11) was found to be same 
as that of Scl monoclonal antibody, while FES 2 monoclonal was 
directed against a different epitope as shown by inhibition ELISA 
studies 
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Therefore, in the present study we have been able to analyse and 
characterize the excretory-secretory products ofS. cervi adult worms. 
The hyperimmune sera raised against the S. cervi E-S product showed 
high antibody titres in S. cervi E-S products and showed the presence 
of 10-12 antigenic components. Out of these 3-4 antigens were 
identified as host serum protein components and one of them being 
albumin. The host serum proteins present in S. cervi E-S products 
could be removed by absorbing with anti-BSA antibodies which 
resulted in the removal of host serum protein bands.The absoption of 
rabbit anti-^ ". cervi E-S serum with BSA removed the antibodies the 
against host serum proteins. The preabsorbed rabbit anti-ScE-S serum 
successfully detected the circulating antigen in filarial patients' sera. 
Fractionation on DEAE-Sephacel column resulted in isolating a 
purified antigen fi-action common with human filarial parasite and 
showing high reactivity with the monoclonal, (detecting filarial 
circulating antigen), the four monoclonal antibodies (FES 2, FES 7, 
FES 9 and FES 11) produced against this purified antigen fraction 
(ScESPFI) showed high reactivity with filarial antigen and did not 
cross react with non-filarial antigens thereby, suggesting their filaria 
specificity. Out of these four monoclonals, three (FES 7, FES 9 and 
FES 11) were found to be directed against the same epitope as that of 
Scl monoclonal antibody, while the fourth (FES 2) was against a 
different epitope. The FES 9 monoclonal antibody in combination with 
rabbit ScE-S polyclonal, showed higher sensitivity for the detection of 
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circulating antigen in filarial patient sera. These findings suggest the 
potential of anti-ScE-S antibodies for developing specific 
immunodiagnostic test based on antigen detection for human filariasis. 
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